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Preface
The first time I heard the term “biofeedback” was in 1995. At that time, I was helping my 
wife (my girlfriend then, a DDS who was pursuing her MS in Dental Surgery) in preparing 
her thesis and experiments. Her study interest was about the Efficacy of Occlusal Splints for 
Treating Sleep Bruxism (Tooth Grinding). Her experiments were to study the Influence of 
Visual and Periodontal Feedbacks on the Accuracy and Sustainability of Biting Force Control. 
The experiments started with development of a handmade, fork-type strain gauge force 
transducer whose analog outputs were AC/DC-converted to digital signals and shown in a 
digital display board (DDB). Each experiment was conducted in two phases: the unanes-
thetized phase and the anesthetized phase. There were two sections for each phase and 
four trials were conducted in each session. In the first session of the unanesthetized phase, 
an unanesthetized subject was asked to maintain biting forces of 5 and 15 kilogram-force 
(kgf), respectively, at the incisor and both sides of first molar regions for 15 seconds, both 
with visual biofeedback from the digits shown in the DDB. In the second session of the same 
phase, the DDB was turned off (without biofeedback) in the last 10 seconds. After complet-
ing the unanesthetized phase, the right upper and lower first molar regions were anesthe-
tized with 2 percent lidocaine. Then the same experiment procedures were conducted again 
in the anesthetized phase. 
The experiments were busy and tedious. During an experiment, all the numbers shown 
in the DDB needed to be observed, read, and recorded on paper. Results were put into a 
spreadsheet for further analysis using statistics tools like SPSS. All these ETL (extract, 
transform, load) operations were done manually. For the 15-second test period, only 
three to five data points were read and written down. It’s in Year 1995, the Age of 
Pentium 486 and Windows 95—a Stone age, from today’s ICT (information and com-
munications technology) point of view.
Now is the 2020s. The emerging technologies and applications have shaped the future of 
many technologies like smart biofeedback.  
This book provides readers with information on research projects and practices in modern 
smart biofeedback. It is designed for medical specialists, clinical practitioners, researchers, 
developers of biofeedback technologies, and scholars and graduate students in the fields 
of biomedical engineering, medicine, physiotherapy, computer engineering, data science, 
and so on. Chapters cover topics such as brain networks, neuromeditation, psychophysi-
ological psychotherapy, physiotherapy, and privacy, security, and integrity of data. 
I am grateful to the chapter authors for their contributions. I especially wish to acknowl-
edge their patience in putting up with repeated requests for revision amid the COVID-19 
pandemic. I would also like to acknowledge Ms. Ana Simcic, Ms. Dajana Pemac, and 
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Introductory Chapter: Smart 
Biofeedback – Perspectives and 
Applications
Edward Da-Yin Liao
1. About this book
This book is about the perspectives and applications in smart biofeedback. The 
chapters of this book provide a glimpse of the research projects and clinical applica-
tions that are underway in smart biofeedback as well as the perspectives of smart 
biofeedback.
Biofeedback is an autonomic feedback mechanism to let people (1) observe their 
physiologic information such as muscle tension, blood pressure, heartbeat rates, 
and brain wave signals, (2) develop awareness of their physiological reactions, 
and (3) learn to change these physiologic responses accordingly. The biofeedback 
mechanism helps people take responsibility for their cognitive, emotional, and 
behavioral changes for better health. A biofeedback process may utilize many and 
various sensors to measure physiologic functions and parameters. Sensory data are 
first collected, analyzed, and then fed back to the human sensor nervous system in a 
simple, direct and immediate way.
Modern biofeedback experiments began in the early 70’s of the last century 
[1–3], with a promising evidence observed on the efficacy of clinical biofeedback 
applications [4–7]. For past five decades, uses of biofeedback techniques have been 
widely seen in health, wellness, awareness, and computer interactive entertain-
ment, including therapies of self regulation of psychiatric and physiologic disorders 
[8–21], rehabilitation [22–28], healthcare [29–31], training activities such as 
balancing [32, 33], postural [34, 35], relaxation [36] and sports [37, 38], develop-
ment of socio-emotional interactions [39, 40], assessment of psychophysiological 
stress [41–44], falling prevention and detection [45], computer game design [46], 
and more.
Smart biofeedback [47–52] is receiving attentions because of the widespread, 
available building blocks of advanced technologies and smart devices that are used 
in effective collection, analysis and feedback of physiologic data. Researchers and 
practitioners have been working on various aspects of smart biofeedback meth-
odologies and applications by using wireless communications [53, 54], Internet 
of Things (IoT) [55, 56], wearables [57, 58], biomedical sensors [59–61], artificial 
intelligence [62], big data analytics [63], clinical virtual reality [64], smartphones 
[65, 66], APPs [67], and so forth. The current paradigm shift in information and 
communication technologies (ICT) such as smart and ultra-compressed sensing, 
generative adversarial network (GAN), analog bio-inspired machine learning, 
trainable neuromorphic signal converting, and quantum computing, has been 
propelling the rapid pace of innovation in smart biofeedback. As a new technol-
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2. Perspectives and applications in smart biofeedback
This book addresses five important topics of the perspectives and  applications 
in smart biofeedback—Brain Networks, Neuromeditation, Psychophysiological 
Psychotherapy, Physiotherapy, and Privacy, Security, and Integrity of Data, described 
as below.
2.1 Brain networks
Human brain is an information-sharing network which is connected by many 
spatially distributed, but functionally linked regions of the brain. Exploration of 
dynamic interactions of the large-scale brain network can construct the relation-
ships among brain regions. It helps understand which and how brain regions actu-
ally cooperate during creative cognition and artistic performance. In past decades, 
neuroimaging studies have investigated the functional connectivity by measuring 
the level of co-activation of resting-state functional magnetic resonance imaging 
(fMRI) time series between brain regions [68]. Recent advancements in smart bio-
feedback technology have paved a promising avenue for real-time, in vivo analysis 
and modeling of nerve synapses in the brain. Electrical neuroimaging [69] that uses 
electroencephalography (EEG) biofeedback [70] as the neuroimaging technique 
has the advantages of online recording of the neuronal activity in real time. As a 
window into the brain, EEG has been used to localize the neural activity in the brain 
non-invasively. Biofeedback, also known as neurobiofeedback or neurofeedback 
(NFB) [71, 72], is a psychophysiological mechanism for training of self-regulation 
and has shown compelling findings about brain function and the neural correlates 
of behavior and cognition.
2.2 Neuromeditation
Over the last years, the soaring public interest in mindfulness meditation has 
raised scientific attention. For many people, mindfulness meditation brings a lot of 
benefits and is considered useful for training attention on cognition and emotion 
simultaneously. However, some of them are either difficult to maintain a disciplined 
practice regularly, or lack of methodologies or tools to develop their meditation 
practice more rapidly. Research studies have observed that many similarities of 
changes in EEG frequency bands trained in cognitive NFB therapeutic protocols are 
found in the mental activity involved in meditation practices [73]. As both medita-
tion and NFB are techniques to train mental states, systems or applications based on 
NFB or real-time EEG biofeedback techniques have the potentials to help develop 
meditation. However, the reliability and accuracy of signal detection remain 
questionable in current neuromeditation applications. It is challenging to describe 
the complex brain activity during meditation by basic EEG analyses [74].
2.3 Psychophysiological psychotherapy
While psychophysiological and behavioral interventions manifest equivalent 
effectiveness for some kinds of psychological problems, most psychotherapeutic 
practices focus on the cognitive procedures. Even though psychophysiological 
approaches that use heart rate variability (HRV) biofeedback in muscle relaxation 
and breathing interventions have shown significant effects in clinical psychothera-
pies, psychophysiological methods are often downplayed [75, 76]. Psychotherapy is 
increasingly emphasizing clinical processes and mechanisms in developing smart 
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biofeedback protocols in psychotherapeutic training programs to mitigate patient’s 
physical and psychological disorders such as headache [77], depression [78], and 
anxiety [79]. As the engagement of an efficacious patient-therapist relationship 
is prominent in psychotherapy [80], development of innovative, artificial- 
intelligence-augmented tools and systems for interpersonal biofeedback [81] is 
required to optimize therapists’ awareness of unconscious interpersonal regulation 
dynamics on a moment-to-moment basis.
2.4 Physiotherapy
Biofeedback has been an established, non-pharmacologic technique in physio-
therapy and rehabilitation to mitigate migraine headache [82], relax pelvic floor 
muscles [83–86], help stoke patients regain movement in paralyzed muscles [87, 88], 
relieve chronic pains [89], and reduce Raynaud’s phenomenon [90]. Recently, a 
combined approach, named Imagined Imitation [91], that integrates traditional 
physiotherapy with NBF appears to establish more therapeutic benefits. In conjunc-
tion with electromechanical physiotherapy, participants who receive NFB training 
sessions get better improved in motor control of their affected arms [92]. The 
mechanism of the effectiveness by combining NFB with physiotherapy to modulate 
brain activity is still yet to explore. However, such a combined approach opens a 
grand door to both researchers and practitioners for design of user interfaces and 
user experience scenarios which drive sound user engagement with proper match of 
the level of challenge, according to the participant’s ability and conditions.
2.5 Privacy, security, and integrity of data
The prospectives and applications in smart biofeedback have to embrace the 
advanced ICT integration. In addition to diagnosis information, demographic, 
medical, and psychological data, as well as historical information such as duration 
of complaints and treatment history, should be well managed [93]. Simultaneous 
acquisition of data from multiple physiological sensors introduces new challenges 
to data management along the path of data life cycle of each data, from sensing, 
measuring, interpreting, transmitting, storing, analyzing, predicting, learning, 
to optimizing. Smart biofeedback belongs to highly interconnected systems and 
applications that demand end-to-end privacy, security, and integrity of data for 
proper operations [94]. Smart biofeedback systems and applications are all built on 
the assumption of reliable and secure communication but are vulnerably exposed 
to various treats and attacks. As more and more smart biofeedback systems and 
applications with IoT, cloud and edge computing implementation are emerging, 
new system architectures and approaches such as blockchains are to develop for 
massively distributed processing, to ensure the privacy, security, and integrity  
of data.
3. How the book is organized
This book consists of six chapters. The remaining of the book is into five sec-
tions to cope with the five specific topics of the perspectives and applications in 
smart biofeedback described above. All the chapters are from academic researchers 
and clinical practitioners on various areas of smart biofeedback. This introductory 
chapter, Chapter 1, describes the nature and purpose of this book and outlines the 
scope, logic and significance of the contents of this book.
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Chapter 2 in the Brain Networks section overviews the recent advances in 
electrical neuroimaging, brain networks and neurofeedback protocols. It starts 
with a review of live Z-score NBF training which uses an EEG normative reference 
database to identify the possibly dysregulated brain regions from the probabilities 
estimated by auto and cross-spectrum of EEG. New advances in electrical neuro-
imaging provide a 12,700-voxel resolution, three-dimensional EEG source location 
that uses swLORETA (weighted standardized low resolution electromagnetic 
tomography) and 19 channels for NBF. Such technologies enable the NFB approach 
to cerebellar and subcortical brain hubs like the thalamus, amygdala and habenula. 
Linking symptoms to dysregulated brain hubs and networks is crucial to help 
patients of NBF training. New development in cerebellar z-score NBF research has 
shown a bright future in NBF for brain networks. Potential applications of future 
swLORETA z-score NBF include helping people with cognition problems as well as 
balance problems, and Parkinsonism.
Chapter 3 in the Neuromeditation section introduces the science and practice 
of neuromeditation. Combining NFB and meditation, neuromeditation moni-
tors brainwave activity to help meditators learn to quickly enter a desired state of 
consciousness and then maintain the state for a period of time for improvements 
in mental health. The history, examples, and research evidence on neuromedita-
tion are reviewed. As researches on both NFB and meditation have found effective 
in the treatment of various mental health concerns, respectively, the efficacy of 
neuromeditation is reviewed with a case study about a middle-aged, Caucasian 
female with anxiety, eating disorder, and post traumatic stress disorder (PTSD) 
mental health history. Assessment results, including a quantitative EEG (qEEG) 
assessment comparing her baseline EEG activity to a clinical database, indicate that 
her concerns most closely match the Quiet Mind style of meditation. A mindfulness 
meditation protocol with eight neuromeditation sessions is identified as the best for 
her concerns and background. Most of the improvements are found directly related 
to the goals and concerns identified in the intake process.
Chapter 4 in the Psychophysiological Psychotherapy section surveys the most 
common eight modalities of biofeedback in clinical psychology and provides the 
perspectives of how biofeedback is applied to manage the psychophysiological 
conditions. It aims to elucidate the clinical settings in psychotherapy practices and 
point out the psychophysiological conditions for biofeedback training. It reviews 
the basic principles of psychophysiology, including the balance mechanism between 
the fight-or-flight (sympathetic) versus the rest-and-digest (parasympathetic) 
pathways in the autonomic nervous system (ANS) where biofeedback can regulate 
and provide balance between sympathetic and parasympathetic responses to miti-
gate psychopathological symptoms and to improve cognitive performance. It dem-
onstrates several successful biofeedback training protocols in clinical psychology, 
including managing stress in anxious patients, managing hyperactivity of children 
with attention deficit hyperactivity disorder (ADHD), managing depression.
Chapter 5 in the Physiotherapy section deals with the problems of chronic pains. 
It surveys six NBF protocols to evaluate the efficacy of NBF training for treat-
ment to chronic pains. At first, it introduces the mechanisms and neural pathways 
underlying pain perception, and describes the brain rhythms associated with 
chronic pains and the identification of neurophysiological correlates of chronic 
pains. The efficacy of the two key NBF modalities, EEG and fMRI, for chronic 
pains are discussed. A NBF protocol with EEG target brain rhythms is provided. It 
surveys the efficacy of various NFB training protocols applied in the management 
of chronic pains, including fibromyalgia, central neuropathic pains in paraplegic 
patients, traumatic brain injury, chemotherapy-induced peripheral neuropathy, 
primary headache, complex region pain syndrome type I, post-herpetic neuralgia, 
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and chronic lower back pains. The feasibility and availability of home-based NFB 
therapy for chronic pains are reviewed. Finally, it discusses the adverse effects asso-
ciated with NFB training and limitations, and provides future recommendations.
Chapter 6 in the Privacy, Security, and Integrity of Data section presents the 
design and applications of the Blockchain-based Medical Data Management System 
(BMDMS) for management of medical health records and biofeedback data. As 
an emerging and prospective technology in ICT, blockchain is featured by its 
privacy, security, and integrity of data so that blockchain-enabled information and 
data will remain safe and secure. BMDMS adopts the smart contract approach to 
reduce the need in trusted intermediators, fraud losses, and accidental or malicious 
exceptions, in order to protect the privacy of patients and medical practitioners. 
Patients can take biofeedback training at home or in any local clinics, hospitals, or 
large medical centers and their medical health records and collected biofeedback 
data can be shared among medical facilities within BMDMS in a secure and safe 
way. The proposed BMDMS framework utilizes big data, analytics, and edge/cloud 
computing technologies, to smartly retrieve the exact amount of data to optimize 
the computing and storage capabilities. BMDMS thus avoids the possible deluge of 
clinic or laboratory data, such as massive data collected from biofeedback sensors.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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an emerging and prospective technology in ICT, blockchain is featured by its 
privacy, security, and integrity of data so that blockchain-enabled information and 
data will remain safe and secure. BMDMS adopts the smart contract approach to 
reduce the need in trusted intermediators, fraud losses, and accidental or malicious 
exceptions, in order to protect the privacy of patients and medical practitioners. 
Patients can take biofeedback training at home or in any local clinics, hospitals, or 
large medical centers and their medical health records and collected biofeedback 
data can be shared among medical facilities within BMDMS in a secure and safe 
way. The proposed BMDMS framework utilizes big data, analytics, and edge/cloud 
computing technologies, to smartly retrieve the exact amount of data to optimize 
the computing and storage capabilities. BMDMS thus avoids the possible deluge of 
clinic or laboratory data, such as massive data collected from biofeedback sensors.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Abstract
Human EEG biofeedback (neurofeedback) started in the 1940s using 1 EEG 
recording channel, then to 4 channels in the 1990s. New advancements in electrical 
neuroimaging expanded EEG biofeedback to 19 channels using Low Resolution 
Electromagnetic Tomography (LORETA) three-dimensional current sources of the 
EEG. In 2004–2006 the concept of a “real-time” comparison of the EEG to a healthy 
reference database was developed and tested using surface EEG z-score neurofeed-
back based on a statistical bell curve called “real-time” z-scores. The “real-time” or 
“live” normative reference database comparison was developed to help reduce the 
uncertainty of what threshold to select to activate a feedback signal and to unify all 
EEG measures to a single value, i.e., the distance from the mean of an age matched 
reference sample. In 2009 LORETA z-score neurofeedback further increased the 
specificity by targeting brain network hubs referred to as Brodmann areas. A symp-
tom check list program to help link symptoms to dysregulation of brain networks 
based on fMRI and PET and neurology was created in 2009. The symptom checklist 
and NIH based networks linking symptoms to brain networks grew out of the 
human brain mapping program starting in 1990 which is continuing today. A goal 
is to increase specificity of EEG biofeedback by targeting brain network hubs and 
connections between hubs likely linked to the patient’s symptoms. New advance-
ments in electrical neuroimaging introduced in 2017 provide increased resolution 
of three-dimensional source localization with 12,700 voxels using swLORETA with 
the capacity to conduct cerebellar neurofeedback and neurofeedback of subcortical 
brain hubs such as the thalamus, amygdala and habenula. Future applications of 
swLORETA z-score neurofeedback represents another example of the transfer of 
knowledge gained by the human brain mapping initiatives to further aid in helping 
people with cognition problems as well as balance problems and parkinsonism. A 
brief review of the past, present and future predictions of z-score neurofeedback 
are discussed with special emphasis on new developments that point toward a 
bright and enlightened future in the field of EEG biofeedback.
Keywords: QEEG, neurofeedback, cerebellar EEG, Z scores, swLORETA
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1. History: raw scores to Z-scores
As previously published [1], normative reference databases serve a vital and 
important function in modern clinical science and patient evaluation, including 
quantitative EEG (QEEG) (see review by Thatcher and Lubar [2]. Clinical norma-
tive databases aid in the evaluation of a wide range of disorders by using statistics 
to estimate the distance from the mean of an age matched normal reference. For 
example, blood constituent normative databases, MRI, fMRI and Positron emission 
tomography (PET), ocular and retinal normative databases, blood pressure norma-
tive databases, nerve conduction velocity normative databases, postural databases, 
bone density normative databases, ultra sound normative databases and motor 
development normative databases, to name a few. A comprehensive survey of exist-
ing clinical normative databases can be obtained by searching the National Library 
of Medicine’s database using the search term “Normative Databases” at http://www.
ncbi.nlm.nih.gov/sites/entrez.
In 1998 the fundamental design concept of real-time Z score biofeedback was 
to use a EEG normative database from birth to old age from a reference group of 
healthy individuals like a real-time blood test comparison to a blood constituent 
normative database but instead it is a EEG normative database [3–6]. The central 
idea was a real-time z-score using the standard bell curve by which probabilities 
for an individual can be estimated using the auto and cross-spectrum of the elec-
troencephalogram (EEG) in order to identify brain regions that are dysregulated 
and depart from expected values. While one- to four-channel z-score biofeedback 
is valuable, the linkage of symptoms and complaints to functional network hubs in 
the brain is best achieved by the use of 19 channels of EEG to compare a patient’s 
EEG to the fMRI and PET human brain mapping studies linked to brain networks 
and using an age matched normative database so that current source localization 
in Brodmann areas (network hubs) and connections between network hubs can be 
computed. Once the linkage is made of symptoms to the weak hubs and connections 
likely linked to symptoms, then an individualized z-score biofeedback protocol can 
be devised. However, in order to compute a z-score to make a linkage to symptoms 
then an accurate statistical inference must be made using the Gaussian distribution 
(i.e., bell curve).
Clinically applied normative databases share a common set of statistical and 
scientific standards that have evolved over the years. The standards include peer-
reviewed publications, disclosure of the inclusion/exclusion criteria, tests of sta-
tistical validity, tests of reliability, cross-validation tests, adequate sample sizes for 
different age groups, etc. Normative databases are distinct from nonclinical control 
groups in their scope and their sampling restriction to clinically normal or other-
wise healthy individuals for the purpose of comparison. Another distinguishing 
characteristic of normative databases is the ability to compare a single individual 
to a population of “normal” individuals in order to identify the measures that are 
distant from normal and the magnitude of deviation. Normative databases them-
selves do not diagnose a patient’s clinical problem. Rather, a trained professional 
first evaluates the patient’s clinical history and clinical symptoms and complaints 
and then uses the results of normative database comparisons to aid in the develop-
ment of an accurate clinical diagnosis.
The real-time EEG z-score is directly related to the sample size for a given age 
group and the variance of the reference normal population distribution at each age. 
However, in order to achieve a representative Gaussian distribution, it is necessary 
to include two major categories of statistical variance: 1) the moment-to-moment 
variance or within-session variance, and 2) between subject variance across an age 
group. In the case of the fast Fourier transform (FFT) there is a single integral of the 
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power spectrum for each subject and each frequency, and therefore, there is only 
between-subject variance in normative databases that use non-instantaneous analy-
ses such as the FFT. The application of a normative database by the use of the FFT 
is recommended to start with symptoms and then to reject or confirm hypotheses 
about brain regions and networks by assessing the EEG, and thereby to then create a 
neurofeedback protocol linked to the patient’s symptoms. Unlike the FFT, the Joint-
Time-Frequency-Analysis (JTFA) z-score is computed in microseconds limited by 
the sample rate of the EEG amplifier; therefore, they are essentially instantaneous 
z-scores. It is necessary under the principals of operant conditioning that contiguity 
not be too fast because the activation of neuromodulators like dopamine are rela-
tively slow and long-lasting [7, 8]. Therefore, 250 msec to about 1 second are com-
monly used intervals between a brain event that meets threshold and the delivery of 
a reinforcing signal for both raw score and z-score EEG biofeedback.
As illustrated in Figure 1, another design concept is simplification and standard-
ization of EEG biofeedback by the application of basic science. Simplification is 
achieved by the use of a single metric, namely, the metric of the z-score for widely 
diverse measures such as power, amplitude asymmetry, power ratios, coherence, 
phase delays, phase-slope-index, phase reset, etc. A virtue of a z-score is metric 
independence and therefore there is no need to argue about absolute thresholds  
e.g., is it 30 μV or maybe 5 μV or maybe 15 μV, or should coherence be 0.6 or 
perhaps 0.9, or phase difference 25° or 62° or 110°, etc.? In addition to removing 
the guesswork, there is also no need to inhibit theta and reinforce beta, since both 
occur at the same time. That is, reinforcing toward z = 0 is a common goal whether 
dysregulation is a negative or a positive outlier because they are treated the same; 
i.e., the event is not reinforced if deviant from normal or distant from z = 0. Artifact 
rejection is another automatic feature of z-score neurofeedback. For example, 
Figure 1. 
Top row is conventional or standard EEG biofeedback in which different units of measurement are used in 
an EEG analysis (e.g., μV for amplitude, theta/beta ratios, relative power 0 to 100%, coherence 0 to 1, phase 
in degrees or radians, etc.) and the clinician must guess at a threshold for a particular electrode location and 
frequency and age for when to reinforce or inhibit a give measure. The bottom row is z-score biofeedback, 
in which different metrics are represented by a single and common metric, i.e., the metric of a z-score, and 
the guesswork is removed because all measures are reinforced to move z-scores toward z = 0, which is the 
approximate center of an average healthy brain state based on a reference age-matched normative database in 
real time. Reprinted with permission from [9]). (Copyright 2012 Anipublishing, Inc.).
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artifact is usually 5 to 20 standard deviations from the non-artifact reference 
normative means and standard deviations, and if the reinforcement range is + 
and – 2 standard deviations, then artifact will not be reinforced, in contrast to raw 
score neurofeedback where movement and EMG artifact, etc. may be reinforced. 
Standardization is also achieved by EEG amplifier-matching of the frequency 
response of the normative database amplifiers to the frequency characteristics of 
the EEG amplifiers used to acquire a comparison to a subject’s EEG time series. 
Without amplifier matching then deviation from normal may be because of the 
amplifier and not the patient’s brain. This is one of the reasons that an amplifier-
matched EEG normative database met FDA standards [9, 10].
1.1 Advances in EEG source localization
EEG source localization was developed in the 1980s and supported by the Human 
Brain Mapping program at the National Institutes of Health starting in 1990 and 
continuing today. Numerous cross-validations and tests of localization accuracy 
have been conducted and are reviewed in Thatcher [9, 10]. LORETA using 2394 MRI 
voxels was developed by Pascual-Marqui and colleagues in 1994 [11]. An improved 
version based on standardization of the source space and using 6200 MRI voxels was 
developed in 2003 called sLORETA. A limitation of LORETA and sLORETA is the 
reliance on a spherical head model because the brain is shaped like a loaf of bread, 
elongated and flat on the bottom, and it is not shaped like a sphere. In addition, the 
volume in the interior of the brain is not homogeneous, which results in reduced 
localization accuracy. In 2007, Ernesto Palmero Soler [12] developed an improved 
inverse solution by mathematically transforming the heterogeneous volume conduc-
tor into a homogeneous volume conductor and also by not using a spherical head 
model. Instead, Soler et al. [12] used a realistic head model using the more precise 
boundary element method (BEM) as well as 12,700 MRI voxels. This method is 
referred to as swLORETA or weighted sLORETA. The BEM plus the use of a homoge-
neous volume conduction results in improved source localization accuracy of deeper 
sources such as from the cerebellum and subthalamus and thalamus, etc. [13, 14].
Figure 2 illustrates the SVD matrix operation to transform the heterogenous 
electrical lead field into a homogenous lead field. Figure 3 shows the results of 
Figure 2. 
Top is the equation for the inverse solution, v = voltage, L = lead field and j = source currents. The SVD 
weighting matrix transforms L into L1 (middle). Bottom row illustrates the transform of the heterogeneous lead 
field L by SVD to produce the homogeneous lead field LW1/2.
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simulations that compared localization accuracy with different numbers of sensors 
for EEG and MEG source localization.
As mentioned previously swLORETA uses a singular value decomposition lead 
field weighting that compensates for varying sensitivity of the sensors to current 
sources at different depths [12–14]. Also a realistic boundary element model (BEM) 
was used for solving the forward problem [15]. The solution was computed using 
12,300 voxels (5.00-mm grid spacing) and it was restricted to the gray matter of 
cerebrum and cerebellum and cerebellar relay nuclei, i.e., red nu., sub-thalamus, 
thalamus. The locations were based on the probabilistic brain tissue maps avail-
able from the Montreal Neurological Institute [16, 17]. Talairach coordinates were 
obtained for every voxel by placing the corresponding Talairach markers onto the 
anatomical template [18]. The final coordinates of the maxima values (x,y,z, Talairach 
coordinates) provided for labeling the corresponding brain areas were based on the 
Talairach atlas. For the definition of cerebellar regions, we used the nomenclature of 
the MRI Atlas of the Human Cerebellum of Schmahmann [19]. In order to reduce the 
number of variables, adjacent frequency 0.5 Hz bins were averaged to produce a 1 Hz 
bin from 1 Hz to 40 Hz for each of the 12,300 gray matter voxels.
1.2 Accuracy of 19 channel EEG inverse solution
The accuracy of the inverse solution as a function of the density of EEG scalp 
electrodes has been discussed extensively since the 1990s with the beginning of 
the NIH human Brain Mapping Project [20]. Low Resolution Electromagnetic 
Tomography (LORETA) was developed in 1994 by Pascual et al. (1994) using 19 
Figure 3. 
Simulations of the cerebral activity by deep sources are simulated using a linear combination of sine functions 
with frequency components evenly spaced in the alpha band (8–12 Hz). The amplitude of oscillation was the 
same for all the frequencies and it was set to 1.0. The 19 channels use the 10–20 positions electrodes system, the 
128 use the 10–10 system and the MEG 148 follows the magnetometer configuration of the 4D neuroimaging 
MAGNES 2500 WH system. In this system, 148 magnetometers are arranged in a uniformly distributed array 
with a mean inter-channel spacing of 2.9 cm. .Left are two thalamic sources located at Talairach coordinates 
[−10–20 8] and [10–20 8]. Right is the same thalamic sources plus a right hemisphere occipital source 
located at [17–100 5]. The error for the thalamic sources in both configurations are EEG −19 = 20 mm; EEG 
−128 = 18 mm; MEG −148 = 14 mm, while for the occipital source the error range from EEG – 19 = 7 mm; EEG 
−128 = 7 mm, MEG = 5 mm.
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artifact is usually 5 to 20 standard deviations from the non-artifact reference 
normative means and standard deviations, and if the reinforcement range is + 
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response of the normative database amplifiers to the frequency characteristics of 
the EEG amplifiers used to acquire a comparison to a subject’s EEG time series. 
Without amplifier matching then deviation from normal may be because of the 
amplifier and not the patient’s brain. This is one of the reasons that an amplifier-
matched EEG normative database met FDA standards [9, 10].
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Figure 2. 
Top is the equation for the inverse solution, v = voltage, L = lead field and j = source currents. The SVD 
weighting matrix transforms L into L1 (middle). Bottom row illustrates the transform of the heterogeneous lead 
field L by SVD to produce the homogeneous lead field LW1/2.
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thalamus. The locations were based on the probabilistic brain tissue maps avail-
able from the Montreal Neurological Institute [16, 17]. Talairach coordinates were 
obtained for every voxel by placing the corresponding Talairach markers onto the 
anatomical template [18]. The final coordinates of the maxima values (x,y,z, Talairach 
coordinates) provided for labeling the corresponding brain areas were based on the 
Talairach atlas. For the definition of cerebellar regions, we used the nomenclature of 
the MRI Atlas of the Human Cerebellum of Schmahmann [19]. In order to reduce the 
number of variables, adjacent frequency 0.5 Hz bins were averaged to produce a 1 Hz 
bin from 1 Hz to 40 Hz for each of the 12,300 gray matter voxels.
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the NIH human Brain Mapping Project [20]. Low Resolution Electromagnetic 
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Figure 3. 
Simulations of the cerebral activity by deep sources are simulated using a linear combination of sine functions 
with frequency components evenly spaced in the alpha band (8–12 Hz). The amplitude of oscillation was the 
same for all the frequencies and it was set to 1.0. The 19 channels use the 10–20 positions electrodes system, the 
128 use the 10–10 system and the MEG 148 follows the magnetometer configuration of the 4D neuroimaging 
MAGNES 2500 WH system. In this system, 148 magnetometers are arranged in a uniformly distributed array 
with a mean inter-channel spacing of 2.9 cm. .Left are two thalamic sources located at Talairach coordinates 
[−10–20 8] and [10–20 8]. Right is the same thalamic sources plus a right hemisphere occipital source 
located at [17–100 5]. The error for the thalamic sources in both configurations are EEG −19 = 20 mm; EEG 
−128 = 18 mm; MEG −148 = 14 mm, while for the occipital source the error range from EEG – 19 = 7 mm; EEG 
−128 = 7 mm, MEG = 5 mm.
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channel EEG recordings and since this time hundreds of 19 channel LORETA stud-
ies have been published. Pascual-Marqui [21] compared five state-of-the-art para-
metric algorithms which are the minimum norm (MN), weighted minimum norm 
(WMN), Low resolution electromagnetic tomography (LORETA), Backus-Gilbert 
and Weighted Resolution Optimization (WROP). Using a three-layer spherical head 
model with 818 grid points (intervoxel distance of 0.133) and 148 electrodes, the 
results showed that on average only LORETA has an acceptable localization error of 
1 grid unit when simulating a scenario with a single source. When comparing MN 
solutions and LORETA solutions with different Lp norms, Yao and Dewald [22] 
have also found out that LORETA with the L1 norm gives the best overall estima-
tion. Grech et al. [23] conducted extensive cross-validation and accuracy tests of 
LORETA, sLORETA, MN, WMN and SLF (Shrinking LORETA FOCUSS) using 
both regularization and no-regularization and two different measures of error.
Songa et al. [24] compared source localization between 19, 32, 64, 128 and 256 
channel EEG recordings. Standardized LORETA (sLORETA) was significantly more 
accurate than the minimum norm (MN) for all comparisons and there was a modest 
reduction in localization error using sLORETA but no significant differences in spatial 
spread nor amplitude estimates [24]. A limitation of the Songa et al. [24] study was not 
using the Boundary Element Method (BEM) to compute a realistic head model f24or 
sLORETA. For example, Songa et al. ([24], p. 20) stated: “With sLORETA standardiza-
tion, if there is an exact match between the head parameters (geometry & conductiv-
ity) that generate the head surface potentials and the head model that is employed 
for the forward model, sampling density and coverage does not matter, and perfect 
(with no noise) source reconstruction is guaranteed. With increasing accuracy of head 
conductivity models that match the individual subject, standardization methods (like 
sLORETA) may become defensible.” As explained in Section 2.6, the current study not 
only used the BEM but, more importantly, used the method of single-value-decom-
position (SVD) to eliminate the heterogeneity of the source space and thereby better 
approximate the zero error properties of sLORETA that Songa et al. [24] discuss.
The improved localization accuracy of cerebellar sources in the present study 
and by Cebolla et al. [13, 14] when using swLORETA is due to both the use of BEM 
and the use of single-value-decompensation (SVD) to transform the heterogeneous 
electrical lead field into a homogeneous lead field similar to the magnetic electroen-
cephalography (MEG) lead field as shown in the bottom row of Figure 3. Figure 3 
shows the comparison between 19 channels and 128 channel EEG in a dipole simula-
tion test [25]. The left column is with two thalamic sources and the right column 
includes one additional source in the right occipital cortex.
The EEG sources were simulated using a linear combination of sine functions 
with frequency components evenly spaced in the alpha band (8–12 Hz). The ampli-
tude of oscillation was the same for all the frequencies and it was set to 1.0. In this 
study we used two source configurations (see Figure 4). The first configuration 
consists of two thalamic sources located at Talairach coordinates [−10–20 8] and 
[10–20 8]. The second configuration consists of the same thalamic sources as in the 
left configuration plus an occipital source located at Talairach coordinates [17–100 5]. 
The error for the thalamic sources in both configurations are EEG −19 = 20 mm; EEG 
−128 = 18 mm; MEG −148 = 14 mm, while for the occipital source the error ranged 
from EEG – 19 = 7 mm; EEG −128 = 7 mm; MEG = 5 mm. Therefore, the simulation 
showed similar localization accuracy between 19 vs. 128 channel surface recordings 
when the standardized weighted swLORETA is used after the use of BEM and SVD to 
produce a homogeneous lead field similar to that used in MEG (bottom row).
Figure 4 is from Soler (2010) that compares the localization accuracy between 
sLORETA and swLORETA and demonstrates not only increased swLORETA 
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Figure 4. 
A comparison of the localization accuracy of sLORETA vs. swLORETA. The X-axis is the signal-to-noise ratio 
(SNR) and the Y-axis are error measurements. (A) is the localization error in millimeters, (B) is the activation 
volume as measured by the number of voxels that are 60% or higher than the maximum current location and 
(C) is the activation probability or how many times out of 300 sources were accurately localized.  Reprinted 
with permission from Soler [26].
Figure 5. 
An example of swLORETA inside of a navigational platform called the NeuroNavigator that allows one 
to navigate through MRI slices, and the MRI volume to view current sources and functional and effective 
connectivity. This includes a symptom checklist and brain, networks known to be linked to symptoms based on 
the human brain mapping program and publications listed in the National Library of medicine (Pubmed). 
Left is the three-dimensional volume view that includes a semi-transparent cortex, diffusion tensor imaging 
(DTI) and coherence between the hubs (Brodmann areas) of the dorsal attention network. Right is the two-
dimensional “Connectome” of the dorsal attention network selected as one of several possible brain networks as 
established by human brain mapping fMRI and PET.
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channel EEG recordings and since this time hundreds of 19 channel LORETA stud-
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channel EEG recordings. Standardized LORETA (sLORETA) was significantly more 
accurate than the minimum norm (MN) for all comparisons and there was a modest 
reduction in localization error using sLORETA but no significant differences in spatial 
spread nor amplitude estimates [24]. A limitation of the Songa et al. [24] study was not 
using the Boundary Element Method (BEM) to compute a realistic head model f24or 
sLORETA. For example, Songa et al. ([24], p. 20) stated: “With sLORETA standardiza-
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ity) that generate the head surface potentials and the head model that is employed 
for the forward model, sampling density and coverage does not matter, and perfect 
(with no noise) source reconstruction is guaranteed. With increasing accuracy of head 
conductivity models that match the individual subject, standardization methods (like 
sLORETA) may become defensible.” As explained in Section 2.6, the current study not 
only used the BEM but, more importantly, used the method of single-value-decom-
position (SVD) to eliminate the heterogeneity of the source space and thereby better 
approximate the zero error properties of sLORETA that Songa et al. [24] discuss.
The improved localization accuracy of cerebellar sources in the present study 
and by Cebolla et al. [13, 14] when using swLORETA is due to both the use of BEM 
and the use of single-value-decompensation (SVD) to transform the heterogeneous 
electrical lead field into a homogeneous lead field similar to the magnetic electroen-
cephalography (MEG) lead field as shown in the bottom row of Figure 3. Figure 3 
shows the comparison between 19 channels and 128 channel EEG in a dipole simula-
tion test [25]. The left column is with two thalamic sources and the right column 
includes one additional source in the right occipital cortex.
The EEG sources were simulated using a linear combination of sine functions 
with frequency components evenly spaced in the alpha band (8–12 Hz). The ampli-
tude of oscillation was the same for all the frequencies and it was set to 1.0. In this 
study we used two source configurations (see Figure 4). The first configuration 
consists of two thalamic sources located at Talairach coordinates [−10–20 8] and 
[10–20 8]. The second configuration consists of the same thalamic sources as in the 
left configuration plus an occipital source located at Talairach coordinates [17–100 5]. 
The error for the thalamic sources in both configurations are EEG −19 = 20 mm; EEG 
−128 = 18 mm; MEG −148 = 14 mm, while for the occipital source the error ranged 
from EEG – 19 = 7 mm; EEG −128 = 7 mm; MEG = 5 mm. Therefore, the simulation 
showed similar localization accuracy between 19 vs. 128 channel surface recordings 
when the standardized weighted swLORETA is used after the use of BEM and SVD to 
produce a homogeneous lead field similar to that used in MEG (bottom row).
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sLORETA and swLORETA and demonstrates not only increased swLORETA 
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A comparison of the localization accuracy of sLORETA vs. swLORETA. The X-axis is the signal-to-noise ratio 
(SNR) and the Y-axis are error measurements. (A) is the localization error in millimeters, (B) is the activation 
volume as measured by the number of voxels that are 60% or higher than the maximum current location and 
(C) is the activation probability or how many times out of 300 sources were accurately localized.  Reprinted 
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An example of swLORETA inside of a navigational platform called the NeuroNavigator that allows one 
to navigate through MRI slices, and the MRI volume to view current sources and functional and effective 
connectivity. This includes a symptom checklist and brain, networks known to be linked to symptoms based on 
the human brain mapping program and publications listed in the National Library of medicine (Pubmed). 
Left is the three-dimensional volume view that includes a semi-transparent cortex, diffusion tensor imaging 
(DTI) and coherence between the hubs (Brodmann areas) of the dorsal attention network. Right is the two-
dimensional “Connectome” of the dorsal attention network selected as one of several possible brain networks as 
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localization accuracy in general but also the ability of swLORETA to image deeper 
sources than sLORETA. This figure illustrates why swLORETA has the ability to 
measure deep EEG sources from structures like the cerebellum and red nucleus due 
to the use of a homogenous lead field, similar to magnetic encephalography (MEG) 
but with the much more powerful electrical field compared to magnetism.
Figure 5 is an example of the swLORETA inverse solution inside of a new and 
powerful viewer called the “NeuroNavigator” that allows one to use a mouse to 
move through MRI slices in the NIH and Montreal Neurological Institute’s template 
MRI [16, 17]. Talairach coordinates were obtained for every voxel by placing the 
corresponding Talairach markers onto the anatomical template [18]. The final coor-
dinates of the maxima values (x,y,z, Talairach coordinates) provided for labeling 
the corresponding brain areas were based on the Talairach atlas. For the definition 
of cerebellar regions, we used the nomenclature of the MRI Atlas of the Human 
Cerebellum of Schmahman [19].
2.  The present: linking symptoms to dysregulated brain hubs and 
networks
A standard FFT normative database analysis should first be computed in order 
to identify the electrode locations and EEG features that are most distant from 
normal and that can be linked to the patient’s symptoms and complaints. Linking a 
subject’s symptoms and complaints, e.g., posttraumatic stress disorder, depression, 
schizophrenia, traumatic brain injury (TBI), etc., to functional localization of net-
works in the brain is an important objective of those who use a normative database. 
Similar to a blood bank analysis, the list of deviant or normal measures are given to 
the clinician as one test among many that are used to help render a diagnosis and to 
plan treatment. Linking dysregulation of neural activity in localized regions of the 
brain to known functional localization (for example, left parietal lobe and dys-
lexia, right frontal and depression, cingulate gyrus and attention deficit, occipital 
lobes and vision problems) are important to help a trained clinician. Textbooks on 
functional localization in neurology and psychiatry are available to aid the clinician 
in learning about the link between a patient’s symptoms and different brain regions 
[27–31]. A link of the anatomical locations and patterns of a patient’s deviant 
z-scores is important in order to derive clinical meaning from the qEEG.
It is the consistency and depth of fMRI, PET, MRI, EEG/MEG studies supported 
by the human brain mapping project that gave rise to the idea of linking patient 
symptoms and complaints to brain network hubs and connections in real-time. In 
1909 Kobian Brodmann [32] conducted remarkable microscopic studies of human 
and monkey cadaver brains where he discovered regions of cortical tissue that 
had a distinct cytoarchitecture of the neurons. Knowing the relationship between 
structure and function, he concluded that the 44 left and 44 right hemisphere areas 
or neural clusters must have different functions. Brodmann’s work was essentially 
forgotten until the 1990 human brain mapping program when suddenly PET and 
fMRI and EEG/MEG confirmed activation of the 88 Brodmann areas by increased 
blood flow and EEG/MEG source localization related to different functions, e.g., 
vision and the visual cortex, movement and the motor cortex, etc. [20, 33].
Dynamic hub functional localization in the brain as evidenced by dysregula-
tion of neural populations in Brodmann areas and hemispheres is fundamental 
to individualized EEG biofeedback. For example, dysregulation is recognized by 
significantly elevated or reduced power or network measures such as coherence and 
phase within network hubs and connections of the brain that sub-serve particular 
functions that can be linked to the patient’s symptoms and complaints. The use of 
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z-scores for biofeedback is designed to re-regulate or optimize the homeostasis, 
neural excitability and network connectivity in particular regions of the brain. 
Most importantly, the functional localization and linkage to symptoms is based 
on modern knowledge of brain function as measured by fMRI, PET, penetrat-
ing head wounds, strokes and other neurological evidence acquired over the last 
two centuries [27, 34] also see the Human Brain Mapping database of functional 
localization at http://hendrix.imm.dtu.dk/services/jerne/brede/index_ext_roots.
html). Thousands of published studies in the National Library of Medicine linking 
symptoms to the brain using fMRI, PET, SPECT, EEG/MEG were made public and 
available through the internet. In 2009, linking clinical symptoms to dysregulation 
in brain networks was the backbone of surface and LORETA z-score neurofeed-
back solely because of the success experienced by patients and advancements in 
neuroscience.
Once an age-matched qEEG normative database comparison is completed, then 
one can use a z-score biofeedback program to train patients to move their instan-
taneous z-scores toward zero or in the direction of the center of the age matched 
normal population. The absolute value and range of the instantaneous z-scores, 
while smaller than those obtained using the FFT offline qEEG normative database, 
are nonetheless valid and capable of being minimized toward zero. An advantage 
of a z-score biofeedback program is simplification by reducing diverse measures to 
a single metric, i.e., the metric of a z-score. Thus, as mentioned previously, there is 
greater standardization and less guesswork about whether to reinforce or suppress 
coherence or phase differences or power, etc. at a particular location and particular 
frequency band (see Figure 1).
2.1 Compensatory vs weak systems
A central concept underlying z-score neurofeedback is distinguishing weak 
systems from compensatory systems. This distinction was emphasized by Luria 
[30] and Teuber [35] in their evaluation of patients with penetrating head wounds, 
strokes and tumors. Modern neuroscience has confirmed the term neuroplasticity 
and neurological compensation in which neural reorganization is measured using 
EEG, fMRI and PET [36–39]. These studies show that when there is reduced 
functionality in a given network then reorganization occurs that involves basic 
neurophysiological mechanisms such as collateral sprouting and compensatory 
hypertrophy [40]. Specialized networks efficiently process information in coordi-
nation with connected modules and hubs in the brain. When there is dysregulation 
or reduced speed and efficiency of information processing in a subregion or a 
functional module, then compensatory reorganization often occurs. An example of 
the role of compensatory reorganization is in an fMRI study of the anxiety network 
and the role of the frontal lobes in regulation and compensation for dysregulation in 
subparts of the amygdala [39].
As mentioned previously, the instantaneous z-scores are much smaller than the 
FFT z-scores in the NeuroGuide software program, which uses the same subjects 
for the normative database. Smaller z-scores when using the instantaneous z-scores 
is expected. One should not be surprised by a 50% reduction in JTFA z-scores in 
comparison to FFT z-scores and this is why it is best to first use 19-channel EEG 
measures and the highly stable FFT z-scores to link symptoms to functional local-
ization in the brain to the extent possible. Then evaluate the patient’s instantaneous 
z-scores as a therapy or protocol design process before the biofeedback procedure 
begins. This will allow one to obtain a unique picture of the EEG instantaneous 
z-scores of each unique patient prior to beginning z-score biofeedback. The clini-
cian must be trained to select which z-scores best match the patient’s symptoms and 
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localization accuracy in general but also the ability of swLORETA to image deeper 
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corresponding Talairach markers onto the anatomical template [18]. The final coor-
dinates of the maxima values (x,y,z, Talairach coordinates) provided for labeling 
the corresponding brain areas were based on the Talairach atlas. For the definition 
of cerebellar regions, we used the nomenclature of the MRI Atlas of the Human 
Cerebellum of Schmahman [19].
2.  The present: linking symptoms to dysregulated brain hubs and 
networks
A standard FFT normative database analysis should first be computed in order 
to identify the electrode locations and EEG features that are most distant from 
normal and that can be linked to the patient’s symptoms and complaints. Linking a 
subject’s symptoms and complaints, e.g., posttraumatic stress disorder, depression, 
schizophrenia, traumatic brain injury (TBI), etc., to functional localization of net-
works in the brain is an important objective of those who use a normative database. 
Similar to a blood bank analysis, the list of deviant or normal measures are given to 
the clinician as one test among many that are used to help render a diagnosis and to 
plan treatment. Linking dysregulation of neural activity in localized regions of the 
brain to known functional localization (for example, left parietal lobe and dys-
lexia, right frontal and depression, cingulate gyrus and attention deficit, occipital 
lobes and vision problems) are important to help a trained clinician. Textbooks on 
functional localization in neurology and psychiatry are available to aid the clinician 
in learning about the link between a patient’s symptoms and different brain regions 
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z-scores is important in order to derive clinical meaning from the qEEG.
It is the consistency and depth of fMRI, PET, MRI, EEG/MEG studies supported 
by the human brain mapping project that gave rise to the idea of linking patient 
symptoms and complaints to brain network hubs and connections in real-time. In 
1909 Kobian Brodmann [32] conducted remarkable microscopic studies of human 
and monkey cadaver brains where he discovered regions of cortical tissue that 
had a distinct cytoarchitecture of the neurons. Knowing the relationship between 
structure and function, he concluded that the 44 left and 44 right hemisphere areas 
or neural clusters must have different functions. Brodmann’s work was essentially 
forgotten until the 1990 human brain mapping program when suddenly PET and 
fMRI and EEG/MEG confirmed activation of the 88 Brodmann areas by increased 
blood flow and EEG/MEG source localization related to different functions, e.g., 
vision and the visual cortex, movement and the motor cortex, etc. [20, 33].
Dynamic hub functional localization in the brain as evidenced by dysregula-
tion of neural populations in Brodmann areas and hemispheres is fundamental 
to individualized EEG biofeedback. For example, dysregulation is recognized by 
significantly elevated or reduced power or network measures such as coherence and 
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functions that can be linked to the patient’s symptoms and complaints. The use of 
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z-scores for biofeedback is designed to re-regulate or optimize the homeostasis, 
neural excitability and network connectivity in particular regions of the brain. 
Most importantly, the functional localization and linkage to symptoms is based 
on modern knowledge of brain function as measured by fMRI, PET, penetrat-
ing head wounds, strokes and other neurological evidence acquired over the last 
two centuries [27, 34] also see the Human Brain Mapping database of functional 
localization at http://hendrix.imm.dtu.dk/services/jerne/brede/index_ext_roots.
html). Thousands of published studies in the National Library of Medicine linking 
symptoms to the brain using fMRI, PET, SPECT, EEG/MEG were made public and 
available through the internet. In 2009, linking clinical symptoms to dysregulation 
in brain networks was the backbone of surface and LORETA z-score neurofeed-
back solely because of the success experienced by patients and advancements in 
neuroscience.
Once an age-matched qEEG normative database comparison is completed, then 
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while smaller than those obtained using the FFT offline qEEG normative database, 
are nonetheless valid and capable of being minimized toward zero. An advantage 
of a z-score biofeedback program is simplification by reducing diverse measures to 
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complaints. A general rule for the choice of z-scores to use for biofeedback depends 
on two factors obtained using a full 19-channel EEG analysis: 1) scalp location(s) 
linked to the patient’s symptoms and complaints, and 2) magnitude of the z-scores. 
Dysregulation by hyperpolarization produces slowing in the EEG, and dysregula-
tion due to reduced inhibition (hypo-polarization) produces deviations at higher 
frequencies. The direction of the z-score is much less important than the location(s) 
of the deviant z-scores and the linkage to the patient’s symptoms and complaints.
2.2 Z-score neurofeedback publications
In 2006 the first real-time z-score biofeedback method (a DLL or dynamic link 
library), was developed by Applied Neuroscience, Inc. (ANI) in 2004, and licensed 
to Brainmaster, Inc. and Thought Technology, LLC. Subsequently, additional EEG 
biofeedback companies such as Mind Media, Inc., Deymed, Inc. Neurofield, Inc. 
and EEG Spectrum implemented the ANI real-time z-score DLL. All implementa-
tions of live z-score EEG biofeedback share the goal of using standard operant 
learning methods to modify synapses in brain networks, specifically networks 
modified by long-term potentiation (LTP) and N-methyl-D-aspartate receptor 
(NMDA) receptors. Operant conditioning is known to involve changes in the same 
NMDA receptors that are modified in long term potentiation LTP, and therefore 
the unifying purpose of z-score biofeedback is to reinforce in the direction of z = 0 
of the EEG, which is the statistical center of a group of healthy normal subjects. 
The normal subjects are a reference just like with blood tests for cholesterol or liver 
enzymes, etc. that shows deviation from a normative reference database.
As of this date no adverse reactions have been published over the last 13 years 
nor have adverse reactions been reported by over 3000 clinicians using z-score 
neurofeedback. This includes six major EEG biofeedback companies, numerous 
clinicians, Veterans Administration and military medical centers, thousands of 
patients and over 60 scientific studies. Below is a partial list of scientific studies 
using z-score EEG biofeedback from 2000 to 2019. Thirty two were published 
in peer-reviewed journals, 31 were book chapters or International Society for 
Neurofeedback & Research (ISNR) NeuroConnections publications, and four were 
reviews and or conference presentations. More published research always important 
and more publications are in progress and will be available in the future. See Table 1 
for a partial list of scientific publications of z-score neurofeedback.
Table 2 is a summary of the types of patients, clinical disorders and contents of 
the above z-score neurofeedback publications listed in Table 1. Some of the pub-
lications included more than one clinical symptom category and some were book 
chapters with case studies and some were book chapters on z-score methods.
A hypothesized reason that the reinforcement of instantaneous z-scores toward 
z = 0 is clinically effective is because “chaotic” regimes and extremes of dysregula-
tion are moments of extreme instantaneous z-scores. Reinforcement of “stable” and 
efficient instances of time results in increased average stability and efficiency in 
dysregulated nodes and connections in networks linked to symptoms. An analogy is 
a disruptive child in a school classroom where the teacher gives a reward to the child 
when the child is quiet and not disruptive. Over time the child will be quiet and 
more cooperative due to the reinforcement. z-score biofeedback is also consistent 
with models of homeostatic plasticity in which the learning rule of local inhibitory 
feedback is increased stability of oscillation around z = 0 [99].
Z-score biofeedback methods are unified by the goal of modifying the brain 
toward greater homeostasis and inhibiting extreme and unstable states. Z-score bio-
feedback has its greatest impact on unstable or dysregulated neural systems because 
unstable systems produce extreme z-scores that are not reinforced and thereby 
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minimized or extinguished by not being reinforced. The center of the normal 
population or the ideal instantaneous z = 0 is only a momentary ideal state in which 
homeostatic and balanced systems oscillate around but never achieve perfect z = 0 
for the entire system. However, on average, unstable neural states that produce large 
• Bell et al. [41]
• Collura et al. [42]
• Collura [43–45]
• Collura [46]
• Collura et al. [47, 48]
• Decker et al. [49]
• Duff [50]
• Frey & Koberda [51]
• Foster & Thatcher [52]
• Gluck & Wand [53]
• Groeneveld et al. [54]
• Guan [55]
• Hammer et al. [56]
• Kaur et al. [57]
• Keeser et al. [58]
• Koberda [59]
• Koberda [60–69]
• Koberda & Frey [70, 71]
• Koberda et al. [71–79]
• Krigbaum & Wigton [80]
• Lambos &Williams [81]
• Little et al. [82]
• Lubar [83]
• Pérez-Elvira et al. [84]
• Pérez-Elvira et al. [85]
• Simkin et al. [86]




• Thatcher et al. [93–95]
• Thompson & Thompson [96]
• Wigton [97]
• Wigton & Krigbaum [98]
Table 1. 












Comparison of the effectiveness of z-score surface/LORETA 19-electrode neurofeedback to standard raw 
score neurofeedback = 1
Normal subjects in Comparison between fMRI vs. z-Score NFB = 1
1- to 19-channel surface EEG z-score neurofeedback Publications = 22
LORETA z-score neurofeedback publications = 45
Table 2. 
Summary of the types of patients, clinical disorders and contents of the z-score neurofeedback publications 
listed in Table 1.
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z-score values (e.g., 3 standard deviations or greater) will be minimized and stable 
neural states that are less than 2 standard deviations will be reinforced. This is the 
same process at a slower speed that occurs with blood tests. For example, a blood 
test shows low blood iron compared to the normal population which results in the 
patient ingesting iron pills, which results in increased blood iron, where z = 0 is  
the mean of the reference normal population. In the case of z-score biofeedback, 
the duration and frequency of unstable states or periods of deregulation are reduced 
as z = 0 is reinforced.
2.3 Peak performance
Peak performance has different meanings for different people. A professional 
golfer who wants to improve his golf game is one thing versus a peak performer traf-
fic controller who wants to do his job better. So being specific about exactly what 
peak performance is for an individual is critical when dealing with the brain. This is 
because the brain is the source of all behavior and there are special skills that each 
person possesses. There is a common misconception that some express by stating: 
“bringing deviant to normal” is the opposite of what is needed when treating peak 
performers with z-score EEG biofeedback. This assumption is a bit off because 
z-score biofeedback is not creating a normal state but rather it is reinforcing stabil-
ity and efficiency with less network chaos in general. For example, momentary 3 to 
6 standard deviations when neurons are not processing information are not rein-
forced but periods of stability and efficiency less than 2 to 3 standard deviations are 
reinforced. Operant conditioning reduces the duration and frequency of dysregula-
tion in brain networks and lengthens the average amount of time that groups of 
neurons are “on-line” and processing information. This represents more neurons 
and more neural resources available at each instant of time.
No human being is perfect, and a peak performer in golf may not be a peak 
performer in running or hitting a baseball, etc. What is in common to peak per-
formance are things like efficient memory networks, attention networks, anxiety 
networks, planning networks, social networks, sensory networks, etc. Therefore, 
in the hands of a qualified clinician it does no harm to interview a peak performer 
and ask questions about brain networks like sensation, memory, concentration, 
attention, anxiety, fear, etc., and then design a z-score protocol to target the brain 
Figure 6. 
Examples of changes in z-scores over neurofeedback sessions from different clinicians from their clinical 
practices from patients with different clinical problems. The Y axis shows z-score values and the X axis shows 
neurofeedback sessions in six different subjects provided by EEG biofeedback clinicians using surface and/or 
LORETYA z-score neurofeedback to train patients.
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regions related to things that the clinician and peak performer believe will help 
improve their peak performance. It is unlikely that peak performers will be harmed 
by increased neural stability and increased efficiency in his or her networks. 
Further, it is important to note that since 2016 numerous EEG biofeedback compa-
nies distributed z-score neurofeedback to hundreds of clinicians that have treated 
thousands of patients and there are no reported examples of a peak performer 
losing skills or a person with a high IQ becoming less intelligent, etc.
2.4 Examples of Z-score change toward Z = 0 over sessions
Reduced z-score values in the direction of z = 0 have been reported in all of the 
z-score neurofeedback studies published thus far. Figure 6 are examples of reduced 
z-scores over sessions shown in a progress chart.
Figure 7 are examples of reduced z-scores over sessions shown in scalp surface 
topographic maps and in LORETA current density maps.
3. The future: cerebellar Z-score neurofeedback
Monkey studies of chemically induced Parkinsonism and Cz scalp SMR EEG bio-
feedback demonstrated reduced Parkinsonism that increased synaptic density and syn-
aptic change in the red nucleus in the SMR group. There were two groups: 1-Dopamine 
degeneration + SMR and 2- Dopamine degeneration + sham SMR [100, 101].
SMR EEG neurofeedback (12–15 Hz) reduced parkinsonism symptoms were 
attributed to reinforcing the cerebellum circuits that do not involve dopamine and 
are a separate and compensatory motor system involved with gait and long move-
ments and legs as one walks. Importantly, the studies of Philippens & Vanwersch 
[100] and Philippens et al., [101] demonstrated a red nucleus change in synaptic 
number and organization in the EEG SMR group. The red nucleus is a relay nucleus 
from the cerebellum the thalamus to motor cortex circuits, with minimal dopamine 
involved. New advances in EEG Neuroimaging such as swLORETA [12] allow for 
the evaluation of deep current sources and connectivity from structures such as 
the cerebellum, red nucleus and the sub-thalamus. This means that in 2019 one can 
reinforce deep non-dopamine cerebellar and red nucleus circuits that may reduce 
Figure 7. 
Examples of reduced z-score values in EEG brain maps in six different subjects in 10 sessions or less from four 
different clinicians, measured from their clinical practice using EEG z-score neurofeedback.
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Parksonism. As demonstrated by Philippens & Vanwersch [100] and Philippens 
et al., [101] in monkeys and in studies using the scalp surface EEG SMR which is 
also directly effects the non-dopamine and non-damaged cerebellar compensatory 
circuits Thompson & Thompson [102].
Currently we are conducting further verification and validation tests of the 
cerebellum and red nucleus and subthalamic sources using tDCS and the Rhomberg 
tests of cerebellar function as well as working with patients with cerebellar infarcts 
and balance disorders. Figure 8 is another example of the future application of 
EEG electrical neuroimaging in the evaluation of epilepsy by measuring both local 
and long-distance effects of an epileptic focus or sharp waves and the effects of the 
epileptic event on healthy or non-epileptic networks. A comprehensive evaluation 
can go beyond localizing the epileptic focus but also understanding the upstream/
downstream effects of the focus on distant networks.
The left side of Figure 9 illustrates some of the anatomical connections of the cer-
ebellum, which is made of three primary lobes: 1) flocculus nodulus (archicerebellum 
balance and body equilibrium), 2) anterior lobe (paleocerebellar motor execution), 
and 3) posterior lobe (neocerebeullum – motor plan and coordination). The right 
side of Figure 8 illustrates real-time changes in current density produced by clusters 
of neurons in the various nodes of the cerebellum, which are listed in Table 3. EEG 
Biofeedback starts with real-time auto and cross-spectral measures within and 
between cerebellar hubs as well as the red nucleus, subthalamus, thalamus and cortex 
as well as the fully network dynamic as discovered in the 1990s through 2010 by the 
Human Brain Mapping program, and is continuing today and in 2020.
Figure 10 shows additional examples of cerebellar EEG sources using 
swLORETA including real-time functional and effective connectivity and real-
time z-score neurofeedback that further confirm the findings of Cebolla et al. [13, 
14]. Also, these findings are consistent with the existing scientific literature and 
long history of the measurement of cerebellar sources from the human scalp EEG 
(search Pubmed National Library of Medicine database “cerebellar EEG”).
Figure 8. 
Example of functional (zero phase lag coherence, lagged coherence and phase difference) and effective 
connectivity (phase-slope index) between all brain network hubs. This figure illustrates the use of electrical 
neuroimaging in epilepsy patients where the focal epileptic event is in the right posterior temporal regions. The 
network analyses allow one to evaluate the local and distant effects on different functional networks and then 
to evaluate changes over time as a function of treatments.
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Figure 9. 
The image on the left illustrates the anatomical connections of the human cerebellum. On the right is 
an example of the cerebellum nodes and connections to the sensory-motor cortex using the swLORETA 
NeuroNavigator (NeuroGuide v. 3.0.7, applied neuroscience, Inc., 2019). Z-scores of the EEG on the scalp 
surface as well as for functional connectivity between the 13 hubs of the cerebellum, plus the red nucleus, 
subthalamus and thalamus. See Table 3 for a list of the swLORETA neurofeedback protocol options.
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Table 3 shows some of the cerebellar options to select for cerebellar EEG 
biofeedback. The cerebellum is made up of three lobes: flocculous nodulous (archi-
cerebellum related to balance and equilibrium), anterior lobe (paleocerebellum 
related to motor execution), and the phylogenetic more recent posterior lobe (neo-
cerebellum related to motor planning). The vermis is linked primarily to balance 
and equilibrium, with vermis X as the nodulous part of the flocculous nodulous that 
receives input from the brainstem vestibular nucleus.
4. Conclusions
The universal efficacy of EEG operant conditioning depends on: 1) A time 
locked external signal to a spontaneously emitted EEG event that predicts a future 
Figure 10. 
Examples of swLORETA source localization and functional and effective connectivity between cerebellar 
sources and the sensory-motor cortex.













Shows the wide range of cerebellar sources to select with swLORETA neurofeedback. The cerebellar lobes, vermis, 
red nucleus, habenula and subthalamus are menu selections for swLORETA neurofeedback based on a patient’s 
symptoms or history such as vertigo, parkinsonism, balance problems.
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reward and, 2) Temporal contiguity where there is a limited time window between 
the emitted EEG event and the feedback signal. A third and important factor is 
specificity provided by new advances in 3-dimensional electrical neuroimaging of 
brain networks, i.e., Positive reinforcement of the “weak” node(s) and connections 
linked to symptoms.
4.1 Value of Z score neurofeedback
The use of 19-channel EEG z-score neurofeedback and EEG source localization 
neurofeedback (LORETA, sLORETA and now swLORETA) can aid in increasing 
specificity based on the patient’s symptoms, informed by the 200 years of neurol-
ogy as well as the human brain mapping program, beginning in 1990 with the 
decade of the brain giving rise to three-dimensional fMRI, PET and EEG/MEG 
assessment of a large number of patients. A unnormalized or raw EEG value fails to 
provide information about the direction of neurofeedback, i.e., whether to reinforce 
or to inhibit a given EEG metric. The use of z-score neurofeedback reduces uncer-
tainty and increases simplicity by reducing measures to a single metric of distance 
from a reference healthy population of age-matched individuals. Reference to a 
healthy age matched group of individuals helps determine the direction of rein-
forcement of an EEG event and helps target the weak hubs to reinforce improved 
regulation and efficiency of brain networks linked to symptoms. The real-time 
z-score metric identifies outliers or extreme values indicating moments of dysregu-
lation that may be linked to symptoms. The human brain mapping program and the 
neurological literature, when used with z-scores, aids in identifying dysregulation 
in the weak hubs and connections of networks linked to symptoms.
This history of z-score neurofeedback, coupled with the science available online, 
leads toward a modern-day EEG biofeedback protocol that starts with the patient’s 
symptoms followed by an online search of the National Library of Medicine data-
base using the search terms “anxiety brain networks,” or “depression brain net-
works,” or “memory brain networks,” or “addiction brain networks,” etc. depending 
on the patient’s symptoms. This is then followed by the selection Brodmann areas in 
the hubs and connections of the relevant networks to produce a protocol to rein-
force increased stability and efficiency of the networks likely linked to the patient’s 
symptoms.
With the development of improved EEG neuroimaging methods such as 
weighted swLORETA using over 12,000 MRI voxels and the boundary element 
method plus the use or a homogeneous lead field improves EEG source localization 
accuracy closer to that achieved by magnetoencephalography (MEG) at a fraction 
of the expense. These new developments indicate a bright and promising future 
for the field of EEG biofeedback by improved source localization accuracy and the 
ability to link a patient’s symptoms to dysregulation in brain networks and connec-
tions known to be related to the patient’s symptoms. In addition, given these new 
and inexpensive technologies, the field of EEG biofeedback can expand by helping 
patients with cerebellar-related problems by enhancing cerebellar compensation in 
movement disorders like parkinsonism. Parkinsonism strikes approximately 60,000 
new patients every year and SMR EEG biofeedback has been shown to reduce the 
severity of parkinsonism by training the non-dopamine motor system comprising 
the cerebellum, red nucleus, subthalamus, thalamus and the sensory-motor cortex 
(SMR = EEG sensory motor rhythms). In the hands of future trained clinicians, 
physical therapists, chiropractors and ear, nose and throat doctors there will be 
an increasing use of QEEG to assess and then train toward an improved clinical 
outcome as demonstrated in human patients [102, 103] as well as in monkeys  
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Table 3 shows some of the cerebellar options to select for cerebellar EEG 
biofeedback. The cerebellum is made up of three lobes: flocculous nodulous (archi-
cerebellum related to balance and equilibrium), anterior lobe (paleocerebellum 
related to motor execution), and the phylogenetic more recent posterior lobe (neo-
cerebellum related to motor planning). The vermis is linked primarily to balance 
and equilibrium, with vermis X as the nodulous part of the flocculous nodulous that 
receives input from the brainstem vestibular nucleus.
4. Conclusions
The universal efficacy of EEG operant conditioning depends on: 1) A time 
locked external signal to a spontaneously emitted EEG event that predicts a future 
Figure 10. 
Examples of swLORETA source localization and functional and effective connectivity between cerebellar 
sources and the sensory-motor cortex.













Shows the wide range of cerebellar sources to select with swLORETA neurofeedback. The cerebellar lobes, vermis, 
red nucleus, habenula and subthalamus are menu selections for swLORETA neurofeedback based on a patient’s 
symptoms or history such as vertigo, parkinsonism, balance problems.
33
Advances in Electrical Neuroimaging, Brain Networks and Neurofeedback Protocols
DOI: http://dx.doi.org/10.5772/intechopen.94326
reward and, 2) Temporal contiguity where there is a limited time window between 
the emitted EEG event and the feedback signal. A third and important factor is 
specificity provided by new advances in 3-dimensional electrical neuroimaging of 
brain networks, i.e., Positive reinforcement of the “weak” node(s) and connections 
linked to symptoms.
4.1 Value of Z score neurofeedback
The use of 19-channel EEG z-score neurofeedback and EEG source localization 
neurofeedback (LORETA, sLORETA and now swLORETA) can aid in increasing 
specificity based on the patient’s symptoms, informed by the 200 years of neurol-
ogy as well as the human brain mapping program, beginning in 1990 with the 
decade of the brain giving rise to three-dimensional fMRI, PET and EEG/MEG 
assessment of a large number of patients. A unnormalized or raw EEG value fails to 
provide information about the direction of neurofeedback, i.e., whether to reinforce 
or to inhibit a given EEG metric. The use of z-score neurofeedback reduces uncer-
tainty and increases simplicity by reducing measures to a single metric of distance 
from a reference healthy population of age-matched individuals. Reference to a 
healthy age matched group of individuals helps determine the direction of rein-
forcement of an EEG event and helps target the weak hubs to reinforce improved 
regulation and efficiency of brain networks linked to symptoms. The real-time 
z-score metric identifies outliers or extreme values indicating moments of dysregu-
lation that may be linked to symptoms. The human brain mapping program and the 
neurological literature, when used with z-scores, aids in identifying dysregulation 
in the weak hubs and connections of networks linked to symptoms.
This history of z-score neurofeedback, coupled with the science available online, 
leads toward a modern-day EEG biofeedback protocol that starts with the patient’s 
symptoms followed by an online search of the National Library of Medicine data-
base using the search terms “anxiety brain networks,” or “depression brain net-
works,” or “memory brain networks,” or “addiction brain networks,” etc. depending 
on the patient’s symptoms. This is then followed by the selection Brodmann areas in 
the hubs and connections of the relevant networks to produce a protocol to rein-
force increased stability and efficiency of the networks likely linked to the patient’s 
symptoms.
With the development of improved EEG neuroimaging methods such as 
weighted swLORETA using over 12,000 MRI voxels and the boundary element 
method plus the use or a homogeneous lead field improves EEG source localization 
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and inexpensive technologies, the field of EEG biofeedback can expand by helping 
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[100, 101]. People over age 65 are prone to having balance problems and there are 
about 40 million Americans older than age 65. Physical therapists measure and use 
exercises and balance tasks to help patients with balance problems with good suc-
cess. Nonetheless, it is likely, given the rapid growth of knowledge in neuroscience, 
that adding a 15- or 20-minute neurofeedback training session that specifically 
targets the brain’s balance system would be effective and harmless.
Education is the key to expanding the applications of EEG biofeedback of all 
types. Whether z-scores or raw scores, because of the deeper fundamental of 
self-organization, which is what is accomplished when using EEG biofeedback. 
Linking symptoms to the patient’s brain based on modern science is what drives the 
future, and because of an absence of serious or debilitating side effects, the FDA has 
exempted EEG biofeedback companies that use battery powered amplifiers from fil-
ing a 510 K form. Caution, however, is always warranted, and education is essential.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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Neuromeditation: The Science 
and Practice of Combining 




Beginning meditators often complain that they do not know if they are “doing 
it right” or give up before realizing significant benefits. Advanced meditators often 
reach a plateau and struggle to reach “the next level” of their practice. Modern 
researchers and practitioners are finding a possible new solution to these challenges 
by using EEG biofeedback to increase awareness of subtle states of consciousness 
and speed the learning process. By tracking brainwave activity in specific regions 
of the brain, we can tell if someone is focused or relaxed. We can tell if the mind 
is wandering, if they are engaged in body-based emotions, or if they have entered 
a space of internal quiet. By monitoring this activity and connecting it directly to 
the intent of the meditation, it is possible to help meditators learn to quickly enter 
a desired state of consciousness and maintain this state for increasing periods of 
time. This chapter will describe the early research conducted in this area along with 
an original case study conducted by the author. In addition, the author will describe 
the way this technology is being used as a treatment intervention for ADHD, 
anxiety, depression, and PTSD.
Keywords: neuromeditation, neurofeedback, meditation, mindfulness,  
EEG biofeedback, neurotherapy
1. Introduction
There is abundant evidence that the practice of meditation can lead to improve-
ments in an array of physical and mental health concerns [1]. Not surprisingly, this 
has led to increasing acceptance of these practices in Western societies. In fact, 
a recent survey found that three of the top four reasons for starting a meditation 
practice related to improved mental health or affect management [2]. Despite the 
increased interest in secular-based meditation programs designed to reduce stress or 
improve mental well-being (e.g., Mindfulness Based Stress Reduction, Mindfulness 
Based Cognitive Therapy), many people continue to find it difficult to begin or 
maintain a consistent practice, giving up before they realize any significant benefit.
Researchers, therapists, and meditation coaches are finding a possible new solution 
to these challenges by using EEG biofeedback to increase awareness of subtle states of 
consciousness and speed the meditation learning process [3–5].
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2. Neurofeedback and meditation
2.1 Neurofeedback explained
Neurofeedback, sometimes referred to as EEG biofeedback, involves measuring 
brain wave activity through an electroencephalogram (EEG) and using that informa-
tion to help the brain understand and modify its processes [6]. Because the raw EEG 
is a complex signal containing a wide range of frequencies, such data are typically 
filtered and organized into clusters, called bins. For example, alpha brainwaves are 
typically identified as the activity occurring between 8 and 12 Hz, while beta brain-
waves can be identified as the activity between 15 and 25 Hz. The amount of activity 
recorded in each of these EEG clusters is measured in microvolts (mv). So, for each 
electrode used in a recording, it is possible to identify an average amount of power 
(mv) for each of the specified EEG bands (e.g., delta, theta, alpha, etc., see Figure 1).
Once the EEG signal has been quantified, it is connected to computer-based 
audio and visual signals (feedback) that change in response to the EEG patterns. 
In this way it is possible to create a pleasant signal that occurs when the brain 
moves in the desired direction and remove the signal when the brain moves in an 
undesired direction. With repeated exposure to this process the brain can learn to 
become more flexible and adaptive, shifting out of rigid states that may be con-
nected to particular concerns, such as ADHD or epilepsy [7]. The neurofeedback 
provider is trained to understand EEG patterns in relation to specific concerns 
and is able to create individualized programs for each client based on their goals 
and needs.
2.2 EEG patterns and states of consciousness
EEG bands are clusters of frequencies, organized into groups based loosely on 
their shape and function. These bands vary in their definition depending on the 
specific researcher or clinician. Typical EEG band ranges and descriptions follow.
Delta waves (0–4 Hz) are the slowest brainwaves. When they are dominant, the 
person is most likely asleep. While we always produce delta activity, if it increases 
significantly in relation to the other EEG bands, it will be very difficult to maintain 
any sort of alert consciousness. Its function appears to be mostly related to rest and 
regeneration.
Theta waves (4–8 Hz) are also considered slow brainwaves, although a bit faster 
than Delta. This band tends to increase during memory retrieval, creative thinking, 
Figure 1. 
Raw, delta, theta, alpha, beta, and gamma EEG bands.
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and the “twilight state” just before falling asleep. Theta waves are often associated 
with the mind being in a more receptive state, such as might occur during hypnosis.
Alpha waves (8–12 Hz) represent our “idle” speed, between the slow and fast 
waves. Alpha is generally associated with being relaxed and internally focused, 
hence its historical connection to meditation. Alpha activity tends to increase in 
the absence of stimulation and is frequently viewed as an inverse indication of 
activation.
Beta waves (12–30 Hz) are fast waves and associated with activation and arousal. 
When beta increases, it is likely that the person is engaged in thinking, planning, 
worrying, or some other active state.
Gamma waves (35–50 Hz) are associated with a very sharp focus and feelings of 
creativity and insight. Increases in this activity are often observed during high-level 
information processing or a more effortless, but complex form of understanding, 
such as occur in a flow state.
2.3 The meditating brain
Contrary to popular belief, there is no single EEG pattern associated with 
meditation. This is largely due to the fact that there are many different approaches 
to meditation with distinctly different ways of directing attention. In addition, each 
style of meditation impacts specific regions of the brain. For example many forms 
of a Focus or Concentration meditation practice result in activation of the frontal 
lobes while simultaneously showing a de-activation of regions in the back of the 
brain.
Based on reviews of the EEG meditation literature, most researchers agree that 
there are four basic styles of meditation defined by how attention is directed, the 
intention of the meditator, which brainwaves are involved, and in which brain 
regions [5, 8, 9]. These four styles can be described as follows:
Focus: Meditative practices with this emphasis involve sustaining attention on 
a single object, such as the breath or a mantra. When the mind wanders, the task is 
to recognize this and return to the original point of focus. Regardless of the specific 
target, practices in this category require sustaining attention and minimizing mind 
wandering. Consequently, neuromeditation approaches with this style in mind 
must monitor specific regions of the frontal lobe (sustaining attention) and the 
Default Mode Network (DMN; mind wandering). The goal is to keep the attention 
circuits activated without becoming caught in self-referencing narratives.
Mindfulness: While the term mindfulness has been popularized to refer to a 
range of practices, it is being used here to describe meditation styles that require the 
meditator to shift into an observer state of awareness, gently watching thoughts, 
feelings, and bodily sensations without attachment. It is a present moment aware-
ness without attempts to control, analyze, or judge the experience. These practices 
also quiet down the Default Mode Network while simultaneously activating the 
Salience Network, which directs attention toward what is important in the moment.
Open heart: These practices involve activating a positive feeling state and 
directing those feelings toward self or others. Practices such as lovingkindness, 
compassion, gratitude, and forgiveness-based meditations fit in this category. These 
practices activate attention networks and brain regions associated with empathy 
and emotional processing.
Quiet mind: Practices in this category represent the stereotype of meditation. 
This is a state in which internal chatter has been reduced to a minimum. Sometimes 
it is described as a feeling of spaciousness or emptiness. This state is common in 
traditions like Zen or Transcendental Meditation (TM). Not surprisingly, the brain 
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patterns connected to these practices show a significant quieting of many regions of 
the brain, including the Default Mode Network and language centers.
3. Understanding Neuromeditation
Simply put, neuromeditation is the combination of meditation with neurofeed-
back. By monitoring brainwave activity in specific regions of the brain, it is possible 
to determine if someone is focused or relaxed, if the mind is wandering, if they 
are engaged in body-based emotions, or if they have entered a space of internal 
quietude. By tracking this activity in real-time and connecting it directly to the 
intent of the meditation, it is possible to help meditators learn to quickly enter a 
desired state of consciousness and maintain this state for increasing periods of time, 
increasing the impact and effectiveness.
3.1 History of Neuromeditation
The practice of combining neurofeedback with meditation is not new. In fact, 
many of the pioneers in the field of neurofeedback were motivated by the desire 
to enhance their meditation practice or explore states of consciousness. Based 
on the research of the time, meditation was primarily associated with increased 
Alpha brainwave activity, particularly in the Occipital and Parietal regions of the 
brain [10, 11]. As a result, rewarding increases in Alpha amplitude in these regions 
became the “go-to” approach to neuromeditation for many years [11]. Because 
increases in the Alpha band are generally related to an inhibition of mental activity 
[12], this approach was useful in achieving Quiet Mind meditative states, consistent 
with certain TM or Zen practices [4, 8]. It was also found that protocols designed 
to reward increases in Alpha amplitude frequently resulted in decreased anxiety, 
feelings of relaxation, and positive emotions, providing mental health benefits to 
those suffering from chronic stress or anxiety [13, 14].
3.2 Neuromeditation example
By placing an EEG electrode near the back of the head, it is possible to gain 
information about the state of the brain’s Default Mode Network (DMN). The 
DMN is a vast network with its primary hub located in the Posterior Cingulate 
Cortex (PCC) of the Parietal lobes (see Figure 2), just beneath electrode site PZ 
(see Figure 3). This area of the brain becomes active when a person is involved 
in self-referential thought [16]. Basically, any thought you have that relates back 
to your view of self or your connection to the world will involve the DMN. Not 
surprisingly, activity in the DMN (and PCC) is connected to mind wandering 
during a meditative practice [17]. Essentially, if you are not fully engaged in the 
intention of the meditation, you are likely thinking about yourself or something 
related to yourself. By quieting the DMN, represented by increases in Alpha 
amplitude or decreases in Beta or Gamma, it is possible to move beyond the typical 
“story-telling” tendencies of the mind and tap into an internalized, peaceful state 
of consciousness.
When the Alpha brainwave patterns increase in this region, it is likely that the 
internal state is more relaxed and the mental activity is inhibited. When Alpha is 
lower, there is likely to be more analyzing, judging, comparing, remembering, or 
planning. By establishing a threshold marker in the neurofeedback software, it is 
possible to identify when the Alpha is “high” or “low.”
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When the Alpha activity increases and moves above the threshold marker, the 
meditator receives some form of pre-determined feedback, letting them know 
they are on the right track. The feedback used for meditation is typically some 
form of audio signal or change in music volume designed to provide information 
without disrupting the meditative state. When the mind wanders, the Alpha 
drops, signaling a change in the audio signal (e.g., decrease in volume). This 
provides direct and nearly immediate feedback to the meditator, allowing them to 
refine their internal awareness.
Figure 2. 
Sagittal MRI slice with highlighting indicating location of the posterior cingulate cortex [15].
Figure 3. 
International 10-20 EEG electrode map.
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patterns connected to these practices show a significant quieting of many regions of 
the brain, including the Default Mode Network and language centers.
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Simply put, neuromeditation is the combination of meditation with neurofeed-
back. By monitoring brainwave activity in specific regions of the brain, it is possible 
to determine if someone is focused or relaxed, if the mind is wandering, if they 
are engaged in body-based emotions, or if they have entered a space of internal 
quietude. By tracking this activity in real-time and connecting it directly to the 
intent of the meditation, it is possible to help meditators learn to quickly enter a 
desired state of consciousness and maintain this state for increasing periods of time, 
increasing the impact and effectiveness.
3.1 History of Neuromeditation
The practice of combining neurofeedback with meditation is not new. In fact, 
many of the pioneers in the field of neurofeedback were motivated by the desire 
to enhance their meditation practice or explore states of consciousness. Based 
on the research of the time, meditation was primarily associated with increased 
Alpha brainwave activity, particularly in the Occipital and Parietal regions of the 
brain [10, 11]. As a result, rewarding increases in Alpha amplitude in these regions 
became the “go-to” approach to neuromeditation for many years [11]. Because 
increases in the Alpha band are generally related to an inhibition of mental activity 
[12], this approach was useful in achieving Quiet Mind meditative states, consistent 
with certain TM or Zen practices [4, 8]. It was also found that protocols designed 
to reward increases in Alpha amplitude frequently resulted in decreased anxiety, 
feelings of relaxation, and positive emotions, providing mental health benefits to 
those suffering from chronic stress or anxiety [13, 14].
3.2 Neuromeditation example
By placing an EEG electrode near the back of the head, it is possible to gain 
information about the state of the brain’s Default Mode Network (DMN). The 
DMN is a vast network with its primary hub located in the Posterior Cingulate 
Cortex (PCC) of the Parietal lobes (see Figure 2), just beneath electrode site PZ 
(see Figure 3). This area of the brain becomes active when a person is involved 
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of consciousness.
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possible to identify when the Alpha is “high” or “low.”
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they are on the right track. The feedback used for meditation is typically some 
form of audio signal or change in music volume designed to provide information 
without disrupting the meditative state. When the mind wanders, the Alpha 
drops, signaling a change in the audio signal (e.g., decrease in volume). This 
provides direct and nearly immediate feedback to the meditator, allowing them to 
refine their internal awareness.
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Sagittal MRI slice with highlighting indicating location of the posterior cingulate cortex [15].
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International 10-20 EEG electrode map.
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It should be noted that the example provided above is an over-simplification of 
the process, but offered for the purposes of illustration.
3.3 The research evidence for Neuromeditation
While the real-world applications of neuromeditation have been explored in 
the neurofeedback community for many years, there have been only a few studies 
demonstrating the power of this approach in the lab. The first study to examine the 
feasibility of neurofeedback for meditation used real-time fMRI data to examine the 
subjective experience of meditators when the Posterior Cingulate Cortex (PCC) was 
active vs. quiet. Rather than measuring EEG activity, this study examined blood 
flow, which is an indication of activation [18].
The meditators in this study reported experiences of being “distracted,” “inter-
preting,” “controlling,” and “efforting,” when the PCC was active. In contrast, they 
reported experiences of “concentration,” “undistracted awareness,” “effortless doing,” 
and “observing sensory experience” when the PCC was deactivated. A follow-up 
study provided feedback to meditators about the activity level of the (PCC) during 
a Focus style of meditation [19]. Both meditators and non-meditators reported a 
significant relationship between activation of the PCC and mind wandering as well 
as deactivation of the PCC and focused attention.
The researchers also found that experienced meditators (but not novice medita-
tors) were able to intentionally decrease activation of the PCC through the use of 
the feedback [18]. In another study using EEG neurofeedback, van Lutterveld, et al., 
found that both novice and experienced meditators were able to control the experi-
ence of effortless awareness in connection with a feedback signal indicating decreased 
PCC activation [20].
More recently, eight sessions of neurofeedback-enhanced meditation were 
compared to a control group that received sham neurofeedback [21]. Rather than 
focusing on the PCC, these researchers rewarded increases of frontal midline theta 
brainwaves (FM Theta). FM Theta are slow oscillations, between 4 and 7 Hz that 
are generated in the Anterior Cingulate Cortex (ACC; see Figure 4). Theta origi-
nating in the ACC often increases in power during a variety of cognitive processes 
Figure 4. 
Sagittal MRI slice with highlighting indicating location of the anterior cingulate cortex [15].
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that require attention, focus, or emotional processing [22–25]. Several studies have 
found a correlation between increased FM Theta and focused attention meditation 
practices [26, 27]. Results showed that the experimental group was not only able 
to significantly increase FM Theta, but also improved performance on a working 
memory task [21].
Video 1 (https://youtu.be/OxMdYj2Jq4Y; [28]) provides a demonstration and 
explanation of a neuromeditation protocol that examines increases of FM Theta 
while simultaneously monitoring (de)activation of the DMN.
4. Neuromeditation for mental health
While most work in the field of neuromeditation has been devoted to enhancing 
or advancing the development of specific meditative states, clinicians and research-
ers are also beginning to explore this strategy as an intervention to improve mental 
health and cognitive functioning. Because both meditation and neurofeedback have 
independently been found to be effective in the treatment of a variety of mental 
health concerns, it is logical to combine them to target specific outcomes [3, 5]. For 
example, in the study cited above subjects receiving eight sessions of focus neuro-
meditation significantly improved their performance on a working memory task, 
while the control group did not [21]. These outcomes make sense given that regions 
of the brain involved in working memory are exercised during Focus meditation 
practices. With this logic, it is possible to identify which styles of meditation might be 
best suited for particular outcomes.
Focus practices with an emphasis on sustaining attention on a single object, 
activate the frontal lobes, making it an ideal practice for improving func-
tions related to attention, memory, or other executive functions [8, 29, 30]. 
Consequently, this might be the most beneficial practice for someone with ADHD, 
cognitive decline, or traumatic brain injury.
Mindfulness, which involves a much more relaxed, observing form of attention 
may be best suited for managing stress and anxiety [31]. A key component of mind-
fulness practices involves non-attachment and learning to let go [32], key elements 
involved in managing stress and anxiety. Not surprisingly, these practices have been 
shown to reduce activation of the Amygdala, a key brain region involved in the fight 
or flight response [33].
Open Heart practices, such as lovingkindness-compassion, and gratitude engage 
positive feeling states, increasing empathy, perspective-taking, and the experience 
of joy and appreciation [8, 30]. These practices can be helpful for those dealing with 
resentment, unresolved grief, anger management, or depression.
Practices in the Quiet Mind category result in a reduction of self-talk, leading to 
the experience of spaciousness or emptiness [8, 34]. Because these practices essen-
tially involve interrupting the “normal” process of “selfing,” they can be helpful for 
concerns connected to a distorted or inaccurate perception of self, which includes 
most mental health concerns.
While the four styles can certainly serve as a guide for matching a person to the 
ideal meditation practice, there are often levels of nuance that require assessment 
and direction from a trained mental health professional. This is particularly true 
for clients engaging in neuromeditation with unresolved trauma. In addition, we 
have found that EEG guided meditation is most effective when it is individualized 
and includes meditation coaching. The case study below will demonstrate this 
approach.
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while the control group did not [21]. These outcomes make sense given that regions 
of the brain involved in working memory are exercised during Focus meditation 
practices. With this logic, it is possible to identify which styles of meditation might be 
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activate the frontal lobes, making it an ideal practice for improving func-
tions related to attention, memory, or other executive functions [8, 29, 30]. 
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fulness practices involves non-attachment and learning to let go [32], key elements 
involved in managing stress and anxiety. Not surprisingly, these practices have been 
shown to reduce activation of the Amygdala, a key brain region involved in the fight 
or flight response [33].
Open Heart practices, such as lovingkindness-compassion, and gratitude engage 
positive feeling states, increasing empathy, perspective-taking, and the experience 
of joy and appreciation [8, 30]. These practices can be helpful for those dealing with 
resentment, unresolved grief, anger management, or depression.
Practices in the Quiet Mind category result in a reduction of self-talk, leading to 
the experience of spaciousness or emptiness [8, 34]. Because these practices essen-
tially involve interrupting the “normal” process of “selfing,” they can be helpful for 
concerns connected to a distorted or inaccurate perception of self, which includes 
most mental health concerns.
While the four styles can certainly serve as a guide for matching a person to the 
ideal meditation practice, there are often levels of nuance that require assessment 
and direction from a trained mental health professional. This is particularly true 
for clients engaging in neuromeditation with unresolved trauma. In addition, we 
have found that EEG guided meditation is most effective when it is individualized 
and includes meditation coaching. The case study below will demonstrate this 
approach.
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Figure 5. 
Absolute power across EEG bands compared to qEEG Pro clinical database.
4.1 Case study
4.1.1 Background
B.A. is a 39-year-old, Caucasian woman with a mental health history of anxiety, 
eating disordered behaviors, and post-traumatic stress disorder (PTSD). The PTSD 
relates to a car accident and childhood sexual trauma.*.
B.A. began working with yogic practices in her 20s. She noted that she would 
frequently experience strong emotions such as grief and anger while holding 
certain poses which led to some resistance to these practices. She began practicing 
Transcendental Meditation during her late 20s, but never felt confident in this 
practice. She described mostly engaging in brief practices and struggles with 
judging herself.
She identified three concerns she hoped to address through her neuromeditation 
practice; these included: a tendency to be hyper-critical of self and others, feeling 
overwhelmed and sensitive to sound, and a desire to feel more grounded-to slow 
down. These were all rated as moderate concerns. In elaboration of item 3, B.A. noted 
that she is “very much in her head” and often feels disconnected from her body.
Known barriers to expanding her current meditation practice include time, 
internal resistance, the critical mind, and a tendency to “leave her body” when she 
begins to relax.
*Identifying information related to this client has been altered to protect their 
identity. In addition, the client has given permission for their case to be shared in 
this format.
4.1.2 Assessment results
Results of the neuromeditation Styles Inventory [35] indicated that her concerns 
most closely matched the Quiet Mind style of meditation. Elevated scores on the 
New Mind Cognitive Emotional Checklist (CEC) Symptom Checklist [36] indicated 
concerns with memory, sensitivity to light and sound, feeling “spacey” or “out of my 
body,” and thinking obsessively. In addition to the above, a Quantitative EEG assess-
ment provided a comparison of her baseline EEG activity to a clinical database. 
Using a Laplacian reference for the eyes closed data set and analyzing it through 
qEEG Pro [37], the most striking feature was increased absolute power across all 
EEG bands in similar brain regions (see Figure 5).
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The EEG analysis indicates that Delta (1–3 Hz) and Theta (4–8) activity were 
elevated in left frontal and parietal regions. These same regions also demonstrated 
elevated Beta (15–20 Hz) and Hibeta (20–30 Hz) which appeared more localized at 
FZ and P3. Alpha activity was largely within normal limits.
The combination of excessive slow and fast activity in similar regions with 
average alpha activity suggests that this pattern may be related to the PTSD concerns 
noted in the interview. Specifically, the increased slow activity may be connected to 
the tendency to dissociate. This pattern could also be related to some of the memory, 
attention, and impulsivity concerns noted in the CEC. The elevated fast activity may 
be related to tendencies toward anxiety as well as sensory sensitivity.
4.1.3 Individualized approach
Based on the information gathered, a Mindfulness meditation protocol was 
identified as the best match for her concerns and background. Specifically, this 
protocol would reward increased activation of the right Insula and deactivation of 
the PCC. Activity in the Right Insula is a common finding in Mindfulness practices 
and relates to interoception, emotional self-awareness [38], and metacognitive 
awareness [39]. The right Insula was highlighted as it tends to be more connected to 
a felt sense of the body and may be helpful in feeling more grounded (one of B.A.’s 
goals). The reduction of activity in the PCC will require a limit on cognitive pro-
cessing such as analysis, comparison, or creating a narrative about the experience. 
This aspect of the protocol addresses concerns around “thinking obsessively.”
4.1.4 Session results
4.1.4.1 Session 1
B.A. was initially instructed to simply observe whatever she notices in her body 
as sensation without any interpretation or internal dialog about these observations. 
Near the 11-min mark of the meditation, B.A. came out of her meditation and com-
mented that she was having trouble feeling into her body and tends to “disappear,” 
feeling nothing. The therapist provided grounding skills training including rubbing 
her fingers together, or tapping her fingers to her thumb to create a tactile sensation. 
B.A. attempted this for approximately 6 min and stopped the session again. She 
noted that she was struggling with this practice. After additional discussion, B.A. 
agreed to try focusing on the heart by imagining breathing into and out of the heart, 
attending to any sensations in that area. After the session, she noted that this seemed 
to work better for her and was assigned as homework. Figure 6 below shows an 
analysis of the session in the neuromeditation Report Writer. Each of the time seg-
ments described above were identified in the EEG record for comparison. The scores 
indicate the percent of time that she was able to keep the identified EEG activity in 
the desired direction. It is clear from examining the right Insula, PCC, and the com-
bined success, that B.A. was much more skilled at reducing activity in the PCC than 
in increasing activity in the right Insula. This is consistent with her report that she 
“felt nothing” and tended to “disappear.” This was also consistent with her history of 
practicing TM meditation, which falls into the Quiet Mind category.
4.1.4.2 Session 2
The session began with a discussion of her home practice during the past week 
(without neurofeedback assistance). We explored her tendency to try too hard, 
become impatient with herself and judge “success.” B.A. was encouraged to relax 
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4.1.4 Session results
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B.A. was initially instructed to simply observe whatever she notices in her body 
as sensation without any interpretation or internal dialog about these observations. 
Near the 11-min mark of the meditation, B.A. came out of her meditation and com-
mented that she was having trouble feeling into her body and tends to “disappear,” 
feeling nothing. The therapist provided grounding skills training including rubbing 
her fingers together, or tapping her fingers to her thumb to create a tactile sensation. 
B.A. attempted this for approximately 6 min and stopped the session again. She 
noted that she was struggling with this practice. After additional discussion, B.A. 
agreed to try focusing on the heart by imagining breathing into and out of the heart, 
attending to any sensations in that area. After the session, she noted that this seemed 
to work better for her and was assigned as homework. Figure 6 below shows an 
analysis of the session in the neuromeditation Report Writer. Each of the time seg-
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The session began with a discussion of her home practice during the past week 
(without neurofeedback assistance). We explored her tendency to try too hard, 
become impatient with herself and judge “success.” B.A. was encouraged to relax 
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her goals and expectations for the practice, allowing time to find the meditative 
space. B.A. was able to connect to sensations in her throat during the session. The 
time periods of the session where this occurred were easily identified with increased 
gamma activity in the R. insula. While this approach appeared successful, B.A. 
reported feeling somewhat “panicky” near the end of the session. B.A. indicated 
that focusing on the throat was causing some trauma related feelings and memories 
connected to a history of sexual abuse. We discussed her reaction briefly, inviting 
her to change the focus of her meditation, engage with eyes open, use a variety of 
grounding tools, or titrating the experience to maintain a feeling of safety.
4.1.4.3 Session 3
B.A. noted that the tendency to dissociate is so strong that it requires a lot of 
energy and effort to stay present. To encourage present focused awareness, B.A. 
began coaching herself internally, reminding herself that she is safe, noting her 
process and experience. While this strategy helped B.A. to stay in her body with-
out dissociating, the internal narrative caused the activity in the PCC to increase. 
Consequently, the EEG analysis for this session showed increased success with the 
R. insula, but decreased success with the PCC.
4.1.4.4 Session 4
B.A. noted more spontaneous experiences of mindfulness outside of session 
and fewer dissociative moments. During the session we altered the instructions and 
Figure 6. 
Analysis of session 1 in the NeuroMeditation report writer. Scores reflect the percent of time that EEG criterion 
was met for specified meditation segments.
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the EEG expectations such that she could use self-talk to help notice her present-
moment experiences. This resulted in the most significant positive results to date. 
In fact, B.A. ended the session claiming that she felt “amazing.” She described the 
meditative state as “feeling without trying to feel.” She described it as an effort-
less awareness of her body in the present moment. Figure 7 shows a comparison 
between the beginning of the session vs. the period of self-coaching. When this 
shift occurred in session, B.A.’s percent of combined success went from 19 to 42%.
4.1.4.5 Sessions 5–8
Once B.A. was able to experience the desired state and learn to do so in a way that 
felt safe without dissociating, she mastered it very quickly. During the next three 
sessions, she continued to demonstrate the ability to quickly find the desired medi-
tative state and maintain it for increasing lengths of time. She also noted experienc-
ing similar meditative moments through the day. B.A. reported feeling that she is 
fully “in her skin” and enjoying it. Table 1 below is a comparison of sessions, 2, 4, 6, 
and 8. By examining the percent of success across each session, her progress is clear.
Figure 7. 
Analysis of session 4 in the NeuroMeditation report writer. Scores reflect the percent of time that EEG criterion 
was met for specified meditation segments.
Score Comparison
Session 2 Session 4 Session 6 Session 8
Mindfulness Combined Score 7% 22% 44% 75%
Gamma Up R. insula 15% 32% 45% 83%
High Beta Down PCC 61% 84% 100% 86%
Table 1. 
Comparison of sessions 2, 4, 6, and 8 in NeuroMeditation report writer.
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meditative state as “feeling without trying to feel.” She described it as an effort-
less awareness of her body in the present moment. Figure 7 shows a comparison 
between the beginning of the session vs. the period of self-coaching. When this 
shift occurred in session, B.A.’s percent of combined success went from 19 to 42%.
4.1.4.5 Sessions 5–8
Once B.A. was able to experience the desired state and learn to do so in a way that 
felt safe without dissociating, she mastered it very quickly. During the next three 
sessions, she continued to demonstrate the ability to quickly find the desired medi-
tative state and maintain it for increasing lengths of time. She also noted experienc-
ing similar meditative moments through the day. B.A. reported feeling that she is 
fully “in her skin” and enjoying it. Table 1 below is a comparison of sessions, 2, 4, 6, 
and 8. By examining the percent of success across each session, her progress is clear.
Figure 7. 
Analysis of session 4 in the NeuroMeditation report writer. Scores reflect the percent of time that EEG criterion 
was met for specified meditation segments.
Score Comparison
Session 2 Session 4 Session 6 Session 8
Mindfulness Combined Score 7% 22% 44% 75%
Gamma Up R. insula 15% 32% 45% 83%
High Beta Down PCC 61% 84% 100% 86%
Table 1. 
Comparison of sessions 2, 4, 6, and 8 in NeuroMeditation report writer.
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4.1.5 Pre-post symptom changes
At the conclusion of each neuromeditation session, B.A. completed the Toronto 
Mindfulness Scale [40]. This is a 13-item self-report scale designed to assess state 
mindfulness with respect to meditation practice. Six items are summed to produce 
a total Curiosity score (α = 0.88), reflecting an attitude of wanting to learn more 
about one’s experiences (e.g., “I was curious to see what my mind was up to from 
moment to moment”), and seven items are summed to produce summed to produce 
a Decentering score (α = 0.82), reflecting a shift from identifying personally with 
thoughts and feelings to relating to one’s experience within a wider field of aware-
ness (e.g., “I was aware of my thoughts and feelings without overidentifying with 
them”). Figure 8 shows her scores for each session.
These results show a consistent increase in Decentering, which is the scale most 
relevant to decreasing stress and anxiety.
B.A. also completed a symptom questionnaire around sessions 4 and 8. Figure 9 
below demonstrates the change in symptoms from Pre-post.
The gray areas at the top of each bar represent the scores during the initial 
assessment, the colored areas represent the most recent scores. Clearly, there was 
a perceived decrease in symptoms, which were most notable in “easily distracted,” 
“filtering,” “hypervigilance,” “reading comprehension,” and “worry.” Most of 
these improvements appear directly related to the goals and concerns  identified 
in the intake process. It is unclear why there would be such improvements in 
reading  comprehension. It is possible that improvements in attention resulted 
in improved reading comprehension. It is also possible that any brain changes 
Figure 8. 
Toronto Mindfulness Scale scores (curiosity, decentering) for client B.A. across sessions 1–7.
Figure 9. 
Session 4 vs. session 8 symptom questionnaire scores for client B.A.
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occurring as a result of the training had a more generalized impact on brain health 
and  functioning, influencing concerns not directly related to the training itself.
5. Conclusions
While combining neurofeedback with meditation is not new, advances in our 
understanding of the neurological mechanisms of meditation have led to a more 
refined approach. Clinicians and researchers are now able to identify different 
meditation styles based not only on the way attention and intention are directed, 
but on brainwave patterns and brain regions involved. This has led to the ability to 
personalize the process, helping meditators choose a meditation style that is most 
likely to address their goals and needs. Indeed, researchers are now beginning to 
show that specific neuromeditation approaches can be used to improve cognitive 
functioning [41], and psychological concerns including anxiety, depression, and 
PTSD [5]. When this process is used in conjunction with meditation coaching, it 
is possible to use neuromeditation as a treatment modality that is individualized, 
and trauma informed. As such, neuromeditation promises to help define and refine 
meditation for the 21st century.
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Biofeedback in Clinical 
Psychology: Modalities and 
Perspectives
Valeska Kouzak, Aloysio Campos da Paz Neto and Ivo Donner
Abstract
Biofeedback is a technique of self-regulation applied by health professionals in 
order to reshape a series of physiological information based in health parameters 
diminishing psychopathological symptoms and improving cognitive performance. 
The biofeedback technique is widely recognized in many countries, leaving no 
doubt about its effectiveness and applicability. In clinical psychology, biofeedback 
has been applied effectively to psychophysiological conditions such as anxiety, 
depression and ADHD. This chapter has the aim to elucidate the techniques applied 
to clinical settings, where psychophysiological conditions are more prone to be 
treated with biofeedback. Moreover, this chapter also evaluates the advances of the 
technique and possible future directions.
Keywords: neurofeedback, HRV, GSR, anxiety, depression, ADHD
1. Introduction
Biofeedback has begun in the early 60’s as a result of the convergence of 
diverse and relatively recently established fields, such as bio-engineering, physi-
ology and psychology. Firstly, biofeedback emerged as a technique of stress con-
trol when studies relating psychological condition and physical disease emerged 
more vigorously. Afterwards, with the development of self-regulation techniques 
for managing physical and emotional burden, biofeedback became more sophisti-
cated in its applications and methods.
Technological advances in instrumentation led to more objective measurements 
of physiological signals, and the measurement + feedback of a subject’s perfor-
mance has been established to improve capacity to control one’s own signals [1]. 
This way, the organism’s immediate response has been used as a live indication of 
self-regulation during training.
Diverse instruments have been applied to self-regulation, such as skin conduc-
tance response, body temperature, cardiac frequency, respiratory frequency, electro-
encephalography (EEG) [2], and recently, functional magnetic resonance imaging. 
The combination of these instruments with theory grounded biofeedback’s basic 
principle, which is to provide awareness about one’s physical condition - creating a 
self-awareness loop - and through the technology, allow psycho-physiological self-
control. Hence, biofeedback provides an organism with a self-referential information 
feedback to be adjusted according to personal needs [3].
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In this sense, it is important to make a distinction between treatment and 
training: treatment is a process in which an individual expects an external agent 
to provide the change for release or suppression of symptoms; on the other hand, 
training asks the individual for their voluntary participation to the same outcome. 
In this chapter biofeedback is considered a training protocol [4] as it requires an 
active participation of the patient in the process.
This technique is characterized by a multidisciplinary and heterogeneous 
application, and in psychology, biofeedback is applied to relive symptoms of many 
psycho-physiological diseases, such as ADHD, anxiety, depression, among others 
[5–9]. Besides that, nowadays biofeedback is also applied as technique for stress 
reduction in non-clinical population - mainly those that have in their routine highly 
demanding situations of emotional control - such as athletes, police-officers, the 
military, executives, students, musicians, for increasing their performance [10–12].
Moreover, there are studies that seek to evaluate the effects of neurofeedback 
training in cognitive and neuro-psychological abilities. Neurofeedback is a form 
of biofeedback that regulates cortical activity using EEG feedback of brain waves. 
Results so far as 2020 have demonstrated an increase of attention [13], working 
memory [14] and executive function performance [15] in cognitive and neuro-
psychological abilities.
As a multidisciplinary area, biofeedback education and training for professionals 
are diverse, existing in the forms of workshops and as university courses. Hence, in 
order to regulate the quality of practitioners, societies have been created, such as the 
Biofeedback Certification International Alliance (BCIA) - one of the most widely 
known and recognized - to evaluate and regulate the knowledge and practice of 
professionals, and provide support for them and their patients.
In summary, the current chapter has the objective to briefly explain through 
examples of biofeedback techniques how biofeedback has been used in psychology 
to ameliorate psychophysiological symptoms of diverse pathologies, as well as how 
it has been used as an instrument to reduce stress and enhance performance.
2. Basic principles of psychophysiology
The autonomic nervous system (ANS) is a regulatory part of our nervous 
system that works to ensure homeostasis - the maintenance of our body’s balance. 
Therefore, vegetative activity is regulated by the ANS. Body temperature, respira-
tion rate, heart rate, digestion, secretions and muscles are regulated by the ANS’s 
activity unconsciously in order to keep the body alive [16].
The ANS is controlled by the central nervous system (CNS) from sub-cortical 
areas (hypothalamus, brain stem, spinal cord and others) but some cortical areas 
also control its activity. Hence, ANS activity is not completely involuntary [17].
The ANS can be divided in two pathways:
a. Sympathetic Pathway: responsible for increasing body activity. To that end, the 
Sympathetic Pathway is also responsible for our fight-or-flight response, such as 
increased heart rate frequency, sweat and respiration, or promoting muscular 
contraction.
b. Parasympathetic Pathway: responsible for decreasing body activity. To that 
end, the Parasympathetic Pathway promotes relaxation of our body, such 
as decreasing heart rate frequency and respiration or allowing muscular 
relaxation.
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Sympathetic and parasympathetic pathways work together to coordinate 
organism function, activating and deactivating over time to maintain body 
balance.
The balance between sympathetic and parasympathetic pathways may be 
briefly explained by the relation between respiration sinus arrhythmia (RSA), that 
is, the influence of sinuatrial node of the heart by inhaling and exhaling move-
ment in heart rate frequency. Therefore, when individuals inhale their heart rate 
frequency increase and when they exhale their heart rate decrease, leading to a 
continuous sympathetic and parasympathetic activity, activating and deactivating 
our body [1]. However, when changes in our homeostasis happens, more sympa-
thetic activity is required, changing our respiration for a fast paced and higher 
inhalation, consequently our heart rate frequency increase, our muscles contracts, 
our body temperature decrease, among others physiological changes. As soon as 
individuals recognize and classify the stressor being a threat or not, the balance can 
be restored [17].
Biofeedback works by regulating the ANS response to the environment, 
providing balance between sympathetic and parasympathetic responses. 
Consequently, another important concept associated to biofeedback is stress [18]. 
Stress can be defined as a body response to external or internal changes affecting 
homeostasis. The cause of stress is defined as the stressor. Usually, stress is associ-
ated to a negative stressor. However, stressors can be all things that affect organism 
balance, there existing positive stressors as well (i.e: marriage, born of a child, 
graduation presentation). Generally, a stressor can be physical (i.e: broken bone), 
metabolic (i.e: diabetes), biological (i.e: Virus), mental (i.e: depression), social 
(i.e: divorce) and cultural (i.e: civil war) [18].
Biofeedback can create awareness of this relationship between stressors 
and body response, helping individuals to regulate their conditions and foster 
well-being.
3. Modalities and perspectives
In this section we intend to provide the most common modalities of bio-
feedback, equipment and the perspective of how it has been applied to manage 
the psychophysiological conditions. The modalities are presented in following 
order:
1. Galvanic Skin Response (GSR);
2. Temperature Biofeedback;
3. Respiratory biofeedback;
4. Surface Electromyography Biofeedback (sEMG);
5. Heart Rate Variability Biofeedback;
6. Electroencephalography (EEG) Biofeedback or Neurofeedback;
7. Functional Magnetic Resonance Neurofeedback (rt-FMRI);
8. Functional near-infrared spectroscopy (fNIRS) Neurofeedback.
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3.1 Galvanic skin response (GSR) biofeedback
One of the first equipment used to demonstrate the correlation between mood 
alterations and physiological changes was the Galvanic Skin Response (GSR). The 
physiological principle that ground this equipment is the direct correlation between 
stress and autonomic response of sweat by the organism. That is, the higher is the 
stress, higher is the sweat of the organism, and vice-versa.
Since sweat is a compound of mineral salt and water, and an excellent electrical 
conductor, its secretion enhances galvanic skin conductance, which can be mea-
sured by two ultra-sensitive sensors to electric current [19].
GSR works based on the following arrangement: the device produces a non-
invasive electrical current of a minimal value, imperceptible to the organism, that 
varies according to skin resistance change with the sweat excretion amount [1]. 
This electrical current might be converted in sounds and/or images that modify 
according to amount changes in skin sweat. In other words, in a sound feedback, 
the device might emit different sound frequencies according the skin conductance, 
such as:
a. A high-pitched sound is emitted when there are an increase of the sweat 
amount;
b. A bass sound is emitted when there is a decrease of the sweat amount.
Consequently, the bass sound would correspond to lower levels of anxiety and 
pitched sound would correspond to higher levels of anxiety. Hence, the sounds 
allow the representation of subject’s physiological response in relation their own 
levels of anxiety and stress [20].
The GSR biofeedback training has been applied to manage stress in anxious 
patients [21], medication resistant epilepsy patient [22] and athletes [23]. In clinical 
setting, this modality is usually applied with other biofeedback technique, such as 
temperature biofeedback or respiratory biofeedback.
3.2 Temperature biofeedback
This biofeedback technique uses body temperature as a parameter, with 
measurements in the majority of cases from the extremities of superior members 
- usually fingers tips or hands. Body temperature is also regulated by autonomic 
response, and a reduction of blood flow in these areas is an indication of high stress 
level whereas passivity is related to higher temperature. Therefore the relationship 
between body temperature and stress is inverse: the higher is the stress, the lower is 
the body temperature [24].
In other words, when blood vessels contract due to stress increase, blood flow 
and therefore temperature diminishes. On the other hand, when the individual 
is relaxed, there is a vasodilation and an increase of blood flow and therefore of 
temperature.
The temperature biofeedback technique is used for relaxation, being a quickly 
responsive indicator, very sensitive to stress variation [21]. This biofeedback training 
can also be arranged to provide sound feedback. For instance, if the individual needs 
to manage stress, a higher pitch sound is played for low temperatures and a bass 
sound for higher temperatures.
In summary, the skin temperature biofeedback consists in regulating the body 
temperature in order to change the autonomic system. It is rarely used alone in 
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clinical setting, which most of the time is associated with other technique such as 
respiration biofeedback to reduce stress symptoms in anxious patient.
3.3 Respiratory biofeedback
Another technique of biofeedback is the respiratory. It has the aim to improve 
ventilation capacity, facilitate carbon dioxide elimination, and develop relaxation 
skills to manage stress and other symptoms [25]. This technique is fundamental 
because it allows an indirect modulation of the autonomic nervous system, mainly 
because inspiration activates the sympathetic pathway and mobilizes the organism 
for action; on the other hand, expiration stimulates the parasympathetic pathway, 
that is involved in homeostatic process (psychophysiological balance) and general 
body relaxation [1, 16, 26].
Respiratory biofeedback training can be done using belt-coupled sensors over 
the thorax circumference and/or abdominal circumference to register data and 
repass it to an encoder that will present information in a comprehensive by way of a 
computer, through bars, graphic, counters, percentage, or even a sound.
To that way, the professional and patient will be able to analyze the respiratory 
frequency (number of respiratory cycles per minute) and the respiratory ampli-
tude (volume of air change) facilitating the regulation of anxiety symptoms for 
instance [1, 25].
In addition, it is important to observe that the thorax belts or abdominal belts 
contribute to the muscular contraction perception, as lungs are dependent on other 
muscles to breathe. Therefore, respiratory biofeedback technology is able to analyze 
abnormal respiratory cycles, such as:
a. Tachypnea (fast respiration, superficial, with high frequency) and;
b. Hyperventilation (deep, fast respiration, with increase of respiration frequency 
and volume).
In both cases, the fast respiration results in unbalanced entrance of carbon 
dioxide and oxygen in the blood, and in diminishing carbon dioxide, the blood 
becomes alkaline. That is, the balance of calcium and potassium in cellular mem-
branes is modified and lead to muscular and nervous dysfunction, such as mental 
fatigue, migraine, dizziness, syncope among others [27, 28].
Respiratory biofeedback is a technique that can be associated with other biofeed-
back techniques to improve treatment effects on humor disorder, anxiety, cardio-
vascular and neurological disease, cognitive and physical performance.
3.4 Surface electromyography biofeedback (sEMG)
Surface electromyography measures electrical activity of muscles by sensors 
placed over the skin, where the activity should be measured. Muscular tension 
signs captured by electrodes are translated in sounds and images, similar to GSR 
biofeedback. Therefore, depending of the training, the following arrangement can 
be proposed:
a. To problems related to muscular tension, for instance temporomandibular 
joint muscle tension, the feedback is related to facial muscle relaxation. The 
feedback might be a pitched sound for muscular tension, and when the muscle 
is relaxed, it might be a bass sound.
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b. To problems related to flaccid muscle, for instance neurological lesion that 
induces to muscle tone loss, the feedback is related to muscle contraction 
for strengthening tone. That is, when the muscle is contracted the feedback 
might be a bass sound, on the other hand when the muscle is relaxed, than the 
feedback might be a pitched sound.
Consequently, the sEMG biofeedback is used not only for general relaxation 
training, but also to treat facial paralysis or movement rehabilitation in cases of 
brain damage.
3.5 Heart rate variability biofeedback
Heart rate variability describes oscillations between heart rate over consecu-
tive intervals, that is, a R-R wave cycle, controlled by autonomic nervous system 
(ANS) over the sinusoidal node. The cardiac frequency is regulated by sympathetic 
and parasympathetic pathways. In other words, the increase of cardiac frequency 
is related to a higher action of sympathetic pathway and the decrease of cardiac 
frequency is related to a higher action of parasympathetic pathway. Heart rate vari-
ability demonstrates heart health, as it is not expected that the heart keeps the same 
frequency, but instead might be able to adjust to adverse condition that is presented 
to the individual [29].
Heart rate variability training is accomplished when the cardiac rhythm enters in 
consonance or synchronicity with the respiratory rhythm, increasing the amplitude 
of heart rate oscillation [29]. This variability is maximized by biofeedback training 
when six respiratory cycles per minute is achieved, which leads to a sinusoidal wave 
similar to sinus arrhythmia [30].
The training is accomplished by observation of cardiac frequency waves and 
respiration and as the waves became consonants, that is, overlapping or “in phase”, 
sound or visual feedback is offered as behavioral reinforcement.
Heart rate variability biofeedback is related to decreased symptoms of many 
clinical conditions such as anxiety, depression, post-traumatic stress disorder, 
insomnia, alcoholism and addiction, mostly because it provides a feeling of well-
being [2, 31].
Besides that, in studies of increasing performance, the sensation of well-being 
induced by the heart rate training demonstrated to be positive for professional 
musicians and dancers [32].
3.6 Electroencephalography (EEG) biofeedback or neurofeedback
In the beginning of the 20th century, Hans Berger, a German Neuropsychiatrist, 
investigated cerebral electrical activity in dogs and other species. From 1920 
onward, Berger’s studies evolved, and through modifications in electrodes and 
decoders, it was possible to finally use an electroencephalogram in humans in 
1924, when Berger used it for the first time despite technical limitations. In 1930, 
Berger published his data about brain wave frequencies registered in his research, 
in which he named brain waves in accordance with Greek letters “alpha” and 
“beta” [33, 34].
During many years such knowledge of brain waves had mainly been for laboratory 
use. Until the evolution of equipment, applications were unknown.
At the 60’s, Barry Sterman investigated brain waves patterns in training cats via a 
behavioral technique called operand conditioning, in which the animal response of 
pressing a bar is increased in frequency according to positive reinforcement, which 
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could be food for instance. Sterman realized that when cats are prepared to press the 
bar, there was an increase of cortical activity in the sensorimotor area to a pattern of 
12–14 Hz, together with a reduction of motor activity followed by muscular relax-
ation. This pattern of cortical activity is denominated the Sensorimotor Rhythm 
(SMR) [35, 36].
Brain wave frequencies are today classified in different groups defined by 






• SMR (12–15 Hz) in sensorimotor area [36].
Moreover, each frequency is associated to specific cognitive, emotional and 
behavioral states. Delta waves are associated with sleep; Theta and Alpha waves are 
associated with working memory, attention and creativity; Beta waves are associ-
ated with intensive cognitive activity and memory; Gamma waves are associated 
with cognitive integration [8, 25].
The EEG Biofeedback training is also called neurofeedback, and can be defined 
as the operant conditioning of brain waves activity by EEG. That is, neurofeedback 
is the behavioral, cognitive or emotional training during electrophysiologic activity 
evaluation. This measure provides a feedback to the subject of their own perfor-
mance, and, as consequence, provides awareness of their own state and of how to 
efficiently achieve an objective. [37].
The neurofeedback arrangement is based on electrodes that are placed in 
the scalp according to international 10/20 system, a converter decomposing the 
electrical activity from cortical neurons in frequency bands as stated above, and 
a software transforming raw information into computer actions (movie, games 
or music) for the training goal. For instance, if an individual has the aim to train 
attention, a protocol might be applied in the central cortex - therefore an electrode 
is placed at the Cz area - and software is programmed to only provide feedback 
when increased activity is detected in a band frequency related to increased atten-
tion (i.e. SMR) [38, 39].
Neurofeedback training became very popular and many researchers and clini-
cians had the opportunity to add and validate data and results. Neurofeedback is 
nowadays tested as a tool to treat ADHD and seizure with specificity and efficacy. 
Therefore, Neurofeedback studies to treat ADHD and seizure have demon-
strated statistical significance in comparative studies such as patient-placebo, 
neurofeedback-medication, and neurofeedback-other treatments in more than two 
studies [40]. Neurofeedback is also becoming frequently applied in clinics to treat 
other pathologies with psychophysiological basis, such as, anxiety, depression and 
insomnia [9, 41, 42].
Therefore, the existing references are sufficient to reinforce its clinical use as 
tool and its increment in research, mainly in the USA, Canada and some European 
countries, such as England, Spain, Italy, Sweden and Austria [6, 36].
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tive intervals, that is, a R-R wave cycle, controlled by autonomic nervous system 
(ANS) over the sinusoidal node. The cardiac frequency is regulated by sympathetic 
and parasympathetic pathways. In other words, the increase of cardiac frequency 
is related to a higher action of sympathetic pathway and the decrease of cardiac 
frequency is related to a higher action of parasympathetic pathway. Heart rate vari-
ability demonstrates heart health, as it is not expected that the heart keeps the same 
frequency, but instead might be able to adjust to adverse condition that is presented 
to the individual [29].
Heart rate variability training is accomplished when the cardiac rhythm enters in 
consonance or synchronicity with the respiratory rhythm, increasing the amplitude 
of heart rate oscillation [29]. This variability is maximized by biofeedback training 
when six respiratory cycles per minute is achieved, which leads to a sinusoidal wave 
similar to sinus arrhythmia [30].
The training is accomplished by observation of cardiac frequency waves and 
respiration and as the waves became consonants, that is, overlapping or “in phase”, 
sound or visual feedback is offered as behavioral reinforcement.
Heart rate variability biofeedback is related to decreased symptoms of many 
clinical conditions such as anxiety, depression, post-traumatic stress disorder, 
insomnia, alcoholism and addiction, mostly because it provides a feeling of well-
being [2, 31].
Besides that, in studies of increasing performance, the sensation of well-being 
induced by the heart rate training demonstrated to be positive for professional 
musicians and dancers [32].
3.6 Electroencephalography (EEG) biofeedback or neurofeedback
In the beginning of the 20th century, Hans Berger, a German Neuropsychiatrist, 
investigated cerebral electrical activity in dogs and other species. From 1920 
onward, Berger’s studies evolved, and through modifications in electrodes and 
decoders, it was possible to finally use an electroencephalogram in humans in 
1924, when Berger used it for the first time despite technical limitations. In 1930, 
Berger published his data about brain wave frequencies registered in his research, 
in which he named brain waves in accordance with Greek letters “alpha” and 
“beta” [33, 34].
During many years such knowledge of brain waves had mainly been for laboratory 
use. Until the evolution of equipment, applications were unknown.
At the 60’s, Barry Sterman investigated brain waves patterns in training cats via a 
behavioral technique called operand conditioning, in which the animal response of 
pressing a bar is increased in frequency according to positive reinforcement, which 
69
Biofeedback in Clinical Psychology: Modalities and Perspectives
DOI: http://dx.doi.org/10.5772/intechopen.94278
could be food for instance. Sterman realized that when cats are prepared to press the 
bar, there was an increase of cortical activity in the sensorimotor area to a pattern of 
12–14 Hz, together with a reduction of motor activity followed by muscular relax-
ation. This pattern of cortical activity is denominated the Sensorimotor Rhythm 
(SMR) [35, 36].
Brain wave frequencies are today classified in different groups defined by 






• SMR (12–15 Hz) in sensorimotor area [36].
Moreover, each frequency is associated to specific cognitive, emotional and 
behavioral states. Delta waves are associated with sleep; Theta and Alpha waves are 
associated with working memory, attention and creativity; Beta waves are associ-
ated with intensive cognitive activity and memory; Gamma waves are associated 
with cognitive integration [8, 25].
The EEG Biofeedback training is also called neurofeedback, and can be defined 
as the operant conditioning of brain waves activity by EEG. That is, neurofeedback 
is the behavioral, cognitive or emotional training during electrophysiologic activity 
evaluation. This measure provides a feedback to the subject of their own perfor-
mance, and, as consequence, provides awareness of their own state and of how to 
efficiently achieve an objective. [37].
The neurofeedback arrangement is based on electrodes that are placed in 
the scalp according to international 10/20 system, a converter decomposing the 
electrical activity from cortical neurons in frequency bands as stated above, and 
a software transforming raw information into computer actions (movie, games 
or music) for the training goal. For instance, if an individual has the aim to train 
attention, a protocol might be applied in the central cortex - therefore an electrode 
is placed at the Cz area - and software is programmed to only provide feedback 
when increased activity is detected in a band frequency related to increased atten-
tion (i.e. SMR) [38, 39].
Neurofeedback training became very popular and many researchers and clini-
cians had the opportunity to add and validate data and results. Neurofeedback is 
nowadays tested as a tool to treat ADHD and seizure with specificity and efficacy. 
Therefore, Neurofeedback studies to treat ADHD and seizure have demon-
strated statistical significance in comparative studies such as patient-placebo, 
neurofeedback-medication, and neurofeedback-other treatments in more than two 
studies [40]. Neurofeedback is also becoming frequently applied in clinics to treat 
other pathologies with psychophysiological basis, such as, anxiety, depression and 
insomnia [9, 41, 42].
Therefore, the existing references are sufficient to reinforce its clinical use as 
tool and its increment in research, mainly in the USA, Canada and some European 
countries, such as England, Spain, Italy, Sweden and Austria [6, 36].
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3.7 Functional magnetic resonance neurofeedback (rt-FMRI)
Another form of neurofeedback is by Functional Magnetic Resonance Image 
(FMRI), that offers data of cerebral activity from hemodynamic signal - Blood 
Oxygenation Level-Dependent (BOLD). Neurofeedback by FMRI is called real 
time Functional Magnetic Resonance Image (rt-FMRI) and has the advantage of 
providing training in deeper and specific regions of the brain and needing fewer 
sessions. Although it is a new technique, it results have been significant [43] in 
cognitive training.
The principle behind FMRI neurofeedback is that magnetic resonance captures 
changes in blood flow during brain activity and feedback on this change can be 
offered to the individual. In neural activation, metabolic demand increases, and 
consequently, oxygenated blood increases to regulate the de-oxygenated arterial 
blood. The increase of oxi-deoxyhemoglobin also increases the resonance signal 
around the activated nervous tissue, so the target area is indicated and a feedback is 
provided about this event.
FMRI neurofeedback is highly spatially precise. On the other hand, it lacks 
temporal precision, and therefore to capture an image it is necessary to wait for the 
neuronal dynamics to happen, which takes a few minutes. This makes the FMRI 
feedback slower than EEG. Therefore, the protocols used in FMRI neurofeedback 
must contemplate this temporal delay [44]. It is a new technique that has proposed 
protocols so far to improve performance, as it requires a very stressful environment 
to accomplish the training, which is the magnetic resonance machine, usually in 
hospitals.
3.8 Functional near-infrared spectroscopy (fNIRS) neurofeedback
The register by functional near-infrared spectroscopy (fNIRS) is similar to the 
magnetic resonance in that brain activity is captured from a BOLD signal. However, 
it differs in that the hemodynamic changes are registered by an infrared light 
spectrum only able to capture activity from layers closer to scalp [45].
The arrangement for this technique consists of a belt with fNIRS sensor placed 
over the scalp, and a computer feedback provided when individuals achieve the 
training goal.
Moreover, neurofeedback training by fNIRS is also recent and has been applied 
to treat depression [46] and improve cognitive performance [47]. It has the advan-
tage of being more accessible, as it involves simpler equipment and less medical 
environment compared to rt-fMRI.
4. Performance optimization biofeedback
Nowadays, as the biofeedback class developed and became used in diverse 
applications, research about its use in non-clinical populations [48], such as with 
athletes, musicians, dancers and executives, have the aim to increase cognitive 
and physical performance [32]. Becoming an efficient tool to sports psycholo-
gists that face the need to help athletes to manage stress in order to better 
perform [49].
There are also studies that search for neurofeedback training in cognitive and 
neuropsychological skills. The results, as of 2020, have been demonstrating an 
increase in attention [13], working memory [14] and executive function [15].
In addition, there are studies in aging populations to provide cognitive reserve as 
their higher life expectancy increases the need of an active aging population [50].
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5. Clinical application in psychology
According to the biofeedback modalities descriptions stated in the third topic of 
the present chapter, it is possible to enumerate the clinical application of biofeed-
back in psychology.
Firstly, to manage stress in anxious patient, which has been the most widespread 
application of biofeedback since the publication of Hardt and Kamiya study in 
1978 [5] by managing alpha waves in neurofeedback training, as well as, in Leher 
protocol training of HRV [51], in which it is achieved when breath and heart rate 
frequency are consonant.
Secondly, to manage hyperactivity of children ADHD children in SMR protocol 
developed by Lubar and Lubar [6] and applied consequently to manage attention 
[9] and associate to metacognitive strategies [7].
Thirdly, with the acknowledge that depression is associate with activation dif-
ferences between hemispheres, therefore Hammond proposed a training protocol to 
balance this interhemispheric difference applied frontally in the cortex [41].
Hence, those protocols are examples of successful training that have been 
applied by many biofeedback clinician as a psychological tool to manage symptoms 
and decrease suffering. Moreover, it is important to highlight how important is to 
associate psychotherapeutic approach to training, as understand psychological and 
psychotherapeutic aspects help clinicians to improve rapport and coping [25].
6. Conclusion
The connection between body and mind is well known in psychology and has 
been a subject of discussion and academic work. Many mental disorders have their 
origin in the central nervous system, and on the other hand the environment also 
has a great impact in our body. Therefore, a biopsychosocial perspective is needed 
in health professionals, to fully attend individuals that search for clinical health in 
psychology. To that extend, biofeedback is a tool that highlights the value of body 
regulation to provide well-being.
The chapter aimed to demonstrated the diverse biofeedback techniques that 
provide self-awareness and help patients to cope with, and manage, symptoms.
Most of the techniques are applied in regulation of sympathetic symptoms 
activated by stress, thus being relevant to coping with a highly demanding contem-
porary life. Self-regulation of stress is connected with the amelioration of anxiety 
symptoms and attention deficits, while providing better emotional and cognitive 
awareness.
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Abstract
Neurofeedback is a novel neuromodulatory therapy where individuals are given 
real-time feedback regarding their brain neurophysiological signals in order to 
increase volitional control over their brain activity. Such biofeedback platform can 
be used to increase an individual’s resilience to pain as chronic pain has been associ-
ated with abnormal central processing of ascending pain signals. Neurofeedback 
can be provided based on electroencephalogram (EEG) or functional magnetic 
resonance imaging (fMRI) recordings of an individual. Target brain rhythms 
commonly used in EEG neurofeedback for chronic pain include theta, alpha, beta 
and sensorimotor rhythms. Such training has not only been shown to improve 
pain in a variety of pain conditions such as central neuropathic pain, fibromyalgia, 
traumatic brain injury and chemotherapy induced peripheral neuropathy, but 
has also been shown to improve pain associated symptoms such as sleep, fatigue, 
depression and anxiety. Adverse events associated with neurofeedback training 
are often self-limited and resolve with decreased frequency of training. Provision 
of such training has also been explored in the home setting whereby individu-
als have been encouraged to practice this as and when required with promising 
results. Therefore, neurofeedback has the potential to provide low-cost yet holistic 
approach to the management of chronic pain.
Keywords: neurofeedback, EEG biofeedback, fMRI biofeedback, chronic pain, pain, 
fatigue, depression, anxiety, sleep
1. Introduction
Neurofeedback [1, 2] is a smart biofeedback platform which provides real-time 
feedback to individuals about their neurophysiological signals in order to achieve 
brain activity associated with therapeutic benefit. Brain activity of an individual is 
measured continuously using an EEG system during the course of neurofeedback 
training and parameters describing neurophysiological signals such as alpha power 
or peak alpha frequency are calculated in real-time [3]. These calculated features 
of ongoing brain activity are then presented to the individual either in an audio 
or visual form [3]. The idea behind this is that through repeated provision of such 
feedback, the individual gains an awareness of their current brain state and can 
identify different mental strategies which help them achieve the desired brain state 
[4]. Once the individual identifies strategies which work for them, they can keep 
practicing them over the course of multiple sessions with the final aim of being able 
to implement these strategies independent of a neurofeedback session.
Neurofeedback has already been investigated extensively for the management 
of several neuropsychiatric conditions [5] such as Attention Deficit Hyperactivity 
Disorder (ADHD) [6], depression and anxiety [7], cognition [8] and stroke 
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rehabilitation [9] for example. Being able to target brain signals through neurofeed-
back can be of great benefit in conditions such as chronic pain. This is because the 
perception of chronic pain depends on how multiple regions of the brain process 
the ascending pain signals [10, 11]. Such central processing of incoming pain 
signals has been shown to be different in chronic pain patients compared to healthy 
participants by a number of studies [12–14]. Considering the brain plays such an 
important in the development and maintenance of chronic pain state, being able 
to target changes in the neurophysiological signal which reflect such brain activity 
using a novel therapy such as neurofeedback is of great interest.
The field of neurofeedback therapy for chronic pain is rapidly developing. 
Several studies have been performed on a range of medical conditions over the last 
decade [15]. The current studies are highly heterogenous with a number of varia-
tions in neurofeedback protocol and delivery [15, 16]. This chapter aims to give an 
overview of the neurophysiological changes observed in chronic pain and how these 
have been targeted by different neurofeedback studies. We also discuss the different 
aspects of neurofeedback protocols which have been used so far and the outcomes 
of these studies in terms of reduction in pain and pain associated symptoms.
2. Neural pathways underlying pain perception
Our understanding of the neuroscience underlying pain has evolved signifi-
cantly over time. Neural pathways involved in pain perception have been shown in 
Figure 1. One of the earliest theories explaining pain was the “specificity theory” 
(Figure 1: Red pathway). According to this theory, pain is experienced when an 
injury to a particular part of the body leads to signals being relayed via nocicep-
tive neurons to the “pain center” [17]. The brain was considered to be a “passive 
recipient of sensory information” [17].
Figure 1. 
Neural pathways underlying pain perception proposed by different pain theories.
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One of the landmark theories which was highly influential in changing this prior 
understanding of pain was the Gate Control Theory by Melzack and Wall (1965) 
[18] (Figure 1: Blue pathway). This theory proposed that several neurons in the 
spinal cord, such as large fibers carrying touch and vibration sensations as well as 
interneurons in substantia gelatinosa of the dorsal horn, modulate the incoming 
signals from the site of pain, thereby influencing the final signal which is transmit-
ted to the brain for processing.
Since then, advances in neuroimaging has revealed that in addition to neu-
ral pathways in the spinal cord, several cortical structures are also involved in 
modulating pain perception [19, 20] (Figure 1: Purple pathway). Some of the 
areas which have been reported to be involved include anterior cingulate gyrus, 
somatosensory cortex, insular cortex, thalamus and prefrontal cortex [19]. These 
findings suggest that there is not a single “pain centre”. Instead, pain is processed 
by a “pain matrix” connecting different parts of the brain, thereby, reinforcing 
the idea that pain perception is a result of several sensory, affective and cognitive 
processes [10, 11]. Therefore, pain experienced by an individual is an integra-
tion of the current information about the painful sensory stimulation and prior 
information from previous experiences which influence the emotions, anxiety, 
attention and expectations of the individual about the pain [21].
Different areas of the cortex constituting the pain matrix project onto the 
hypothalamus and amygdala, which then give rise to both descending inhibitory 
pathways and descending facilitatory pathways [21, 22]. These descending path-
ways directly project onto the dorsal horn of the spinal cord where gating of pain 
is occurring, therefore, influence the signals which are relayed up the ascending 
pathways [21, 22]. This process is known as top-down modulation of pain [23].
In summary, the pain perceived by an individual is an integration of how 
different parts of the cortex process the ascending pain signals as well as how 
the activity of these cortical and subcortical structures influence the ascending 
pain signals via descending pathways [17, 21, 24]. With the discovery of these 
higher-order processes which influence pain perception, several neuromodula-
tory therapies such as neurofeedback (NFB), hypnosis and meditation, have been 
explored with the potential of controlling pain by influencing this supraspinal 
cortical processing of pain [25].
3. Brain rhythms associated with chronic pain
Generally, the EEG oscillations are categorized based on their frequency into 
theta (4–7 Hz), alpha (8–12 Hz), low beta or beta1 (15–20 Hz) and high beta or beta2 
(22–30 Hz) [26–29]. Another oscillation which is widely investigated in the field of 
neuromodulation is sensorimotor rhythm (SMR). SMR refers to oscillations in the 
12–15 Hz range which appear in spindle-like pattern over the sensorimotor cortex 
during idling of the motor cortex [30, 31]. Motor execution or motor imagery which 
activates the motor cortex leads to a decrease in the SMR activity [31].
Each of these brain rhythms is associated with a specific cognitive state. For 
instance, whilst alpha waves have been associated with a relaxed state, beta waves 
are associated with wakefulness and a state of engagement in task. Theta waves have 
been associated with drowsiness [27, 32].
Patients with chronic pain have differences in their resting-state brain (EEG) 
oscillations from healthy individuals. An example of a chronic pain condition which 
has been extensively investigated for identification of EEG correlates of chronic 
pain has been spinal cord injury (SCI). A study by Sarnthein et al. [12] showed that 
SCI patients with central neuropathic pain had increased activity of theta and beta 
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pain has been spinal cord injury (SCI). A study by Sarnthein et al. [12] showed that 
SCI patients with central neuropathic pain had increased activity of theta and beta 
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oscillations compared to healthy individuals. These findings were confirmed by 
another study [13] which observed similar increases in theta and beta activity, but 
in addition, also identified lower levels of alpha activity in this patient population. 
This association between chronic pain and EEG changes was further strengthened 
when Jensen et al. [33] demonstrated that even within a group of patients with 
spinal cord injury, individuals with central neuropathic pain had higher theta and 
lower alpha activity than patients with spinal cord injury but no chronic pain.
These patterns of EEG have also been reported in other chronic pain conditions. 
For instance, patients with migraine have higher theta and delta power compared 
to healthy controls [14]. Patients with fibromyalgia have been shown to have higher 
theta activity with sources estimated to be in the left dorsolateral prefrontal and 
orbitofrontal cortex, higher beta and gamma activity with sources estimated to be 
in the insular, primary motor and primary and secondary somatosensory cortices 
and slowing of the dominant alpha peak [34].
Identification of such neurophysiological correlates of chronic pain is important 
as it not only provides the necessary feedback signal to increase voluntary control 
in therapies such as neurofeedback, but also allows monitoring the efficacy of the 
therapy in modulating the neurophysiological processes targeted by the therapy.
4. Neurofeedback training protocols
There are two key modalities which have been used to provide neurofeedback – 
EEG neurofeedback and fMRI neurofeedback. Whilst EEG neurofeedback provides 
feedback based on the neurophysiological signals recorded through an EEG system, 
fMRI neurofeedback provides feedback based on the degree of activation of a par-
ticular region of the brain detected using fMRI imaging in real time [35]. Hence it is 
inevitable that there is some lag between the activation and signal detection in fMRI 
neurofeedback which happens almost instantaneously in EEG neurofeedback [35].
Evidence regarding efficacy of fMRI neurofeedback in pain is limited under-
standably due to the increased difficulties and expenses associated with this form. 
The common region of interest which has been targeted in fMRI studies has been 
rostral anterior cingulate gyrus (rACC), whereby increased activity of rACC, mea-
sured through detecting an increase in blood oxygen level dependent signal from 
the region, has been associated with pain reduction [36, 37]. However, these studies 
have been severely limited in terms of number of sessions [37, 38], therefore the full 
benefit of the neurofeedback which occurs over the course of several sessions has 
not been explored yet in fMRI neurofeedback for chronic pain.
A number of brain rhythms have been targeted by EEG neurofeedback in order 
to increase resilience to pain (Table 1). The commonly targeted rhythms include 
theta (4–7 Hz), alpha (8–13 Hz), beta (14–30 Hz) and sensorimotor (12–15 Hz over 
the sensorimotor area) [17]. However, the change desired in each of these rhythms 
varies. Whilst pain reduction has been associated with an increase in the power 
of alpha and sensorimotor rhythms, contrastingly, a decrease in theta and beta 
rhythms have been associated with pain relief [17]. However, very few studies target 
these signals in isolation [20, 39]. More often studies target multiple signals at the 
same time, whereby patients are either shown each rhythm individually at the same 
time or they are shown feedback based on the ratio of two such signals [40–43].
In general, neurofeedback sessions tend to be 30–45 minutes long and patients 
are offered 20–40 sessions [15]. The frequency of these sessions ranges from one 
to five times a week, but studies which administered more frequent sessions have 
reported greater pain relief. Commonly used electrodes for providing feedback 
include C3, C4, Cz, T3, T4, FP1, P3 and P4 [15].
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Feedback has been provided in a range of ways. Auditory feedback has been 
mainly in the form of changing volume of sound, whereby, achievement of signal 
has been associated with an increase in the volume heard [44]. Visual feedback 
used has been more varied (Figure 2). Some studies use simple bars to show the 
feedback, whereby the height of the bar is proportional to the intensity of the signal 
[45]. Other studies have changed the color of the bar on achievement of signal such 
that when the threshold is met, the color turns green, otherwise it remains red [43]. 
Some studies have tried to engage the users through the idea of games whereby the 
width of a river increases as the intensity of signal increases for instance [41, 46]. 
Therefore, feedback has been provided in a range of ways. Another form of stimula-
tion which can be explored in the context of neurofeedback is tactile stimulation. 
Some studies have even combined two forms of stimuli such as visual and auditory 
whereby patient is shown an angry and shouting patient [36]. In order to calm the 
patient, the individual has to achieve the desired changes in the brain rhythms.
5. Efficacy of neurofeedback in management of chronic pain
Several neurofeedback studies have shown pain reduction following neuro-
feedback. Key randomized controlled trials in the field have been summarized in 
Table 2. Reduction in pain has been reported across several pain conditions such as 
Fibromyalgia [27, 29, 36, 41], Central Neuropathic Pain in Paraplegic patients  
[28, 43, 47–49], Traumatic Brain Injury [39, 50], Chemotherapy-Induced Peripheral 
Neuropathy [51], Primary Headache [52], Complex Regional Pain Syndrome Type I 
[53], Post-Herpetic Neuralgia [37] and chronic lower back pain [54]. There is a wide 
Brain rhythm Frequency Desired change
Theta 4–7 Hz Decrease in power
Alpha 8–13 Hz Increase in power







Schematic representation of visual stimulus provided in different neurofeedback studies.
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oscillations compared to healthy individuals. These findings were confirmed by 
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These patterns of EEG have also been reported in other chronic pain conditions. 
For instance, patients with migraine have higher theta and delta power compared 
to healthy controls [14]. Patients with fibromyalgia have been shown to have higher 
theta activity with sources estimated to be in the left dorsolateral prefrontal and 
orbitofrontal cortex, higher beta and gamma activity with sources estimated to be 
in the insular, primary motor and primary and secondary somatosensory cortices 
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ticular region of the brain detected using fMRI imaging in real time [35]. Hence it is 
inevitable that there is some lag between the activation and signal detection in fMRI 
neurofeedback which happens almost instantaneously in EEG neurofeedback [35].
Evidence regarding efficacy of fMRI neurofeedback in pain is limited under-
standably due to the increased difficulties and expenses associated with this form. 
The common region of interest which has been targeted in fMRI studies has been 
rostral anterior cingulate gyrus (rACC), whereby increased activity of rACC, mea-
sured through detecting an increase in blood oxygen level dependent signal from 
the region, has been associated with pain reduction [36, 37]. However, these studies 
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benefit of the neurofeedback which occurs over the course of several sessions has 
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A number of brain rhythms have been targeted by EEG neurofeedback in order 
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of alpha and sensorimotor rhythms, contrastingly, a decrease in theta and beta 
rhythms have been associated with pain relief [17]. However, very few studies target 
these signals in isolation [20, 39]. More often studies target multiple signals at the 
same time, whereby patients are either shown each rhythm individually at the same 
time or they are shown feedback based on the ratio of two such signals [40–43].
In general, neurofeedback sessions tend to be 30–45 minutes long and patients 
are offered 20–40 sessions [15]. The frequency of these sessions ranges from one 
to five times a week, but studies which administered more frequent sessions have 
reported greater pain relief. Commonly used electrodes for providing feedback 
include C3, C4, Cz, T3, T4, FP1, P3 and P4 [15].
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Feedback has been provided in a range of ways. Auditory feedback has been 
mainly in the form of changing volume of sound, whereby, achievement of signal 
has been associated with an increase in the volume heard [44]. Visual feedback 
used has been more varied (Figure 2). Some studies use simple bars to show the 
feedback, whereby the height of the bar is proportional to the intensity of the signal 
[45]. Other studies have changed the color of the bar on achievement of signal such 
that when the threshold is met, the color turns green, otherwise it remains red [43]. 
Some studies have tried to engage the users through the idea of games whereby the 
width of a river increases as the intensity of signal increases for instance [41, 46]. 
Therefore, feedback has been provided in a range of ways. Another form of stimula-
tion which can be explored in the context of neurofeedback is tactile stimulation. 
Some studies have even combined two forms of stimuli such as visual and auditory 
whereby patient is shown an angry and shouting patient [36]. In order to calm the 
patient, the individual has to achieve the desired changes in the brain rhythms.
5. Efficacy of neurofeedback in management of chronic pain
Several neurofeedback studies have shown pain reduction following neuro-
feedback. Key randomized controlled trials in the field have been summarized in 
Table 2. Reduction in pain has been reported across several pain conditions such as 
Fibromyalgia [27, 29, 36, 41], Central Neuropathic Pain in Paraplegic patients  
[28, 43, 47–49], Traumatic Brain Injury [39, 50], Chemotherapy-Induced Peripheral 
Neuropathy [51], Primary Headache [52], Complex Regional Pain Syndrome Type I 
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range of pain reduction reported which can range from an average of 6–82% reduc-
tion in pain intensity [15]. A recent systematic review published showed that ten 
out of twenty-one studies published in the field reported a pain reduction of greater 
than 30% which is considered to be clinically significant reduction [15].
Such variability in the degree of pain reduction could be due to a number of 
aspects of the neurofeedback protocol ranging from number of sessions, frequency 
of sessions, target frequencies and electrodes used for feedback, for example. The 
neurofeedback studies conducted so far have been highly variable on more than one 
of these aspects [15, 16], making comparison of results across studies impossible. 
Therefore, it is difficult to determine which of these parameters is responsible for 
the difference or how to best optimize each of these aspects of the training.
Most of the neurofeedback studies have measured changes in pain immediately 
following neurofeedback [39, 43, 52, 55, 56]. Furthermore, pain reduction has 
been reported to be sustained even at follow up of 3–6 months after completion of 
neurofeedback training [28, 36, 41, 49–51, 54]. However, these studies do not report 
whether the corresponding change in brain rhythm which were measured following 
completion of training were also sustained at long-term follow-up. We do not know 
the length of time for which the effect of neurofeedback on brain rhythms is sus-
tained. Interestingly, one study reported that although pain reduction did not occur 
immediately following completion of the training course, there was improvement 
in pain at follow-up [36]. This could suggest that perhaps NFB could lead to changes 
in the underlying brain networks which occurs over a longer period of time but can 
be sustained for longer duration. These results provide the preliminary evidence for 
potential of neurofeedback for providing analgesia in chronic pain.
It has been shown that neurofeedback not only leads to reduction in pain but 
leads to improvement in a number of pain associated symptoms such as depression 







symptoms reported to 
improve following NFB

















































Randomized controlled trials investigating role of neurofeedback in chronic pain conditions.
85
Neurofeedback for Chronic Pain
DOI: http://dx.doi.org/10.5772/intechopen.93826
[27, 39, 41, 54, 57–60], anxiety [27, 41, 54, 57, 59], fatigue [27, 29, 41, 49, 51], and 
sleep [36, 39, 49–51, 57]. These symptoms have been known to co-exist with pain in 
chronic pain conditions and also known to exacerbate the individual’s pain on a day-
to-day basis [61–63]. Therefore, by being able to target these symptoms along with 
pain, neurofeedback has the potential to holistically improve the well-being of these 
individuals. A summary of different symptoms which have been shown to improve 
following neurofeedback have been shown in Figure 3.
Current neurofeedback studies have a number of limitations. There are currently 
only seven controlled trials in the field [29, 41, 47, 51, 52, 64, 65], of which only 
one trial is of high quality [65]. Most of the trials lack appropriate blinding as the 
control group are often patients on other pain medications [29, 66]. This makes the 
blinding of patient difficult and could lead to patient’s belief in treatment affecting 
the results. Only two studies have implemented sham neurofeedback [36, 37].
The best sham treatment to offer is debatable. One would argue that patients 
could be shown the feedback signal from another region of the brain. But this 
might not be best as it might be the case that another region which is used for 
feedback might be the undiscovered part of the pain matrix. Another way to pro-
vide sham feedback would be to show the individual the recording from another 
participant or their own recording in a reverse order. Whilst this might be a true 
sham condition as the feedback shown to the individual would be independent 
of the individual’s brain activity, it might mean that the patients find no relief of 
symptoms and discover that it is a sham treatment. Either way, such sham neuro-
feedback needs to be implemented by more studies in order to truly understand 
whether the pain reduction reported in these individuals is due to underlying 
changes in neuronal networks.
Whilst we have learnt a lot about neurofeedback over the past decade, there is 
still a lot which is unknown about this technique. Neurofeedback differs from other 
neuromodulatory techniques such entrainment and transcranial magnetic stimula-
tion in that neurofeedback involves active involvement of the individuals in changing 
Figure 3. 
Schematic representation of pain and pain associated symptoms in chronic pain syndromes.
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range of pain reduction reported which can range from an average of 6–82% reduc-
tion in pain intensity [15]. A recent systematic review published showed that ten 
out of twenty-one studies published in the field reported a pain reduction of greater 
than 30% which is considered to be clinically significant reduction [15].
Such variability in the degree of pain reduction could be due to a number of 
aspects of the neurofeedback protocol ranging from number of sessions, frequency 
of sessions, target frequencies and electrodes used for feedback, for example. The 
neurofeedback studies conducted so far have been highly variable on more than one 
of these aspects [15, 16], making comparison of results across studies impossible. 
Therefore, it is difficult to determine which of these parameters is responsible for 
the difference or how to best optimize each of these aspects of the training.
Most of the neurofeedback studies have measured changes in pain immediately 
following neurofeedback [39, 43, 52, 55, 56]. Furthermore, pain reduction has 
been reported to be sustained even at follow up of 3–6 months after completion of 
neurofeedback training [28, 36, 41, 49–51, 54]. However, these studies do not report 
whether the corresponding change in brain rhythm which were measured following 
completion of training were also sustained at long-term follow-up. We do not know 
the length of time for which the effect of neurofeedback on brain rhythms is sus-
tained. Interestingly, one study reported that although pain reduction did not occur 
immediately following completion of the training course, there was improvement 
in pain at follow-up [36]. This could suggest that perhaps NFB could lead to changes 
in the underlying brain networks which occurs over a longer period of time but can 
be sustained for longer duration. These results provide the preliminary evidence for 
potential of neurofeedback for providing analgesia in chronic pain.
It has been shown that neurofeedback not only leads to reduction in pain but 
leads to improvement in a number of pain associated symptoms such as depression 
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[27, 39, 41, 54, 57–60], anxiety [27, 41, 54, 57, 59], fatigue [27, 29, 41, 49, 51], and 
sleep [36, 39, 49–51, 57]. These symptoms have been known to co-exist with pain in 
chronic pain conditions and also known to exacerbate the individual’s pain on a day-
to-day basis [61–63]. Therefore, by being able to target these symptoms along with 
pain, neurofeedback has the potential to holistically improve the well-being of these 
individuals. A summary of different symptoms which have been shown to improve 
following neurofeedback have been shown in Figure 3.
Current neurofeedback studies have a number of limitations. There are currently 
only seven controlled trials in the field [29, 41, 47, 51, 52, 64, 65], of which only 
one trial is of high quality [65]. Most of the trials lack appropriate blinding as the 
control group are often patients on other pain medications [29, 66]. This makes the 
blinding of patient difficult and could lead to patient’s belief in treatment affecting 
the results. Only two studies have implemented sham neurofeedback [36, 37].
The best sham treatment to offer is debatable. One would argue that patients 
could be shown the feedback signal from another region of the brain. But this 
might not be best as it might be the case that another region which is used for 
feedback might be the undiscovered part of the pain matrix. Another way to pro-
vide sham feedback would be to show the individual the recording from another 
participant or their own recording in a reverse order. Whilst this might be a true 
sham condition as the feedback shown to the individual would be independent 
of the individual’s brain activity, it might mean that the patients find no relief of 
symptoms and discover that it is a sham treatment. Either way, such sham neuro-
feedback needs to be implemented by more studies in order to truly understand 
whether the pain reduction reported in these individuals is due to underlying 
changes in neuronal networks.
Whilst we have learnt a lot about neurofeedback over the past decade, there is 
still a lot which is unknown about this technique. Neurofeedback differs from other 
neuromodulatory techniques such entrainment and transcranial magnetic stimula-
tion in that neurofeedback involves active involvement of the individuals in changing 
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the brain oscillations, as opposed to passive reception of stimulation [5]. We do 
not know which of these is a more efficient technique to alter brain oscillations yet. 
Furthermore, it is also unknown what mental strategies in particular are associated 
with changes in brain oscillations seen in the studies so far. Some of the common 
instructions given to patients undergoing training involve asking them to stay 
relaxed, imagining happy moments, revisiting happy memories and thinking about 
favorite family member or friends. However, none of the studies so far document 
which of these strategies actual work for the patients. Therefore, further qualitative 
studies are required to see what patients have been using to actively change their 
brain oscillations during neurofeedback in order to provide more focused instruc-
tions to patients undergoing training. Furthermore, studies should aim to analyze the 
correlation between neurophysiological signal and pain reduction rather than solely 
focusing on the behavioral outcomes [29, 41, 47, 51, 52, 64, 65]. Establishing such cor-
relation between behavioral change and changes in neurophysiological signal is key to 
understanding whether the pain relief is truly due to neurofeedback.
In addition to this, there is also a possibility that once the patients have been able 
to identify the mental strategy which allows them to achieve the desired brain state 
and practice in the neurofeedback setting for a number a sessions, they might be 
able to implement such mental strategies without the ongoing EEG signal feedback. 
It is not clear if this possible or how long it might take for an individual to become 
independent of the EEG feedback and still receive pain relief.
The current neurofeedback studies are highly heterogenous. It is unclear which 
brain regions, oscillations, feedback form or training length is required to optimize 
the improvement in pain. More studies are required comparing one aspect of the 
neurofeedback training program at once in order to determine which of these 
parameters provide the most therapeutic benefit.
Another area of uncertainty is the efficacy of neurofeedback in different pain 
conditions. Studies so far have shown that all chronic pain condition report pain 
reduction to some degree following neurofeedback. However, it is not known 
whether neurofeedback is better for some chronic pain conditions than others. It 
might be the case that neuronal changes seen following neurofeedback is linked to 
central sensitization only, in which case several chronic pain conditions may benefit 
from it equally as many pain conditions have this as the underlying pathology. 
However, we do not know whether it is equally as good at treating nociceptive pain 
as seen in conditions such as arthritis.
Furthermore, the role that neurofeedback will play in pain management in the 
future is not clear [16]. It is not clear whether it has the true potential to substitute 
pharmacological agents completely. It might be the case that it might reduce the 
escalation of opioid usage in this patient cohort. Hence further studies are needed 
to determine the maximum potential of this form of therapy.
6. Adverse effects associated with Neurofeedback
In general, neurofeedback is well tolerated with a minority of patients experienc-
ing mild adverse events. These adverse events are often self-limiting and tend to be 
controlled by decreasing the frequency of training [43, 48]. Adverse events seen 
in neurofeedback studies seem to be more common in certain patient groups than 
others. For instance, some individuals with spinal cord injury and central neuropathic 
pain have reported some hypersensitivity of soles of the feet due to recovery of pro-
prioception or spasms of the lower limb, [28, 48]. Patients with traumatic brain injury 
have reported an increase in nausea and the intensity of their headaches [39, 67]. It is 
difficult to confirm that these side-effects are due to NFB as these reported symptoms 
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are often seen in these conditions irrespective of provision of neurofeedback therapy. 
Overall, NFB is safe and well-tolerated in majority of patients in most clinical studies.
7. Delivery of home-based neurofeedback therapy
Neurofeedback has also been delivered in the home setting by a few recent 
studies [43, 48]. This can be achieved through the use of a headset which records 
activity from one single electrode, such as C4 [43, 48] or FP1 [39] and makes use of 
an app on tablets to analyze and showcase feedback to the individual [28, 48]. Such 
systems have been implemented in patients with central neuropathic pain [43, 48] 
as well as traumatic brain injury [39]. Patients could practice neurofeedback for 
5- or 10-minutes sessions as and when they wanted.
These studies have shown some promising results. With further expansion of this 
technology, it might be possible for individuals to benefit from neurofeedback at their 
home as and when required as patients have on average used neurofeedback 3–40 
times over the course of 2–3 months in these studies [43, 48]. Two of these studies have 
reported around 33% reduction in pain [43, 48] whereas one of them reported 16% 
reduction in pain [39] on average in participants who tried these home-based systems.
One of these studies also performed qualitative research on user experience 
following such home-based systems [43]. Overall, it was reported that the patient 
satisfaction score was high when measured using QUESB (Quebec User Evaluation of 
Satisfaction Questionnaire). According to the patients, the key factors which affected 
the frequency of their use of the home-based device were their health state, availability 
of free time and their intensity of pain. Patients also put effectiveness, ease of use and 
comfort as their main priority when using any such home-based device. Hence whilst 
the current home-based technology used in this study showed that it could record the 
data with decent quality, it also highlighted that patients wanted technology which 
was able to provide neurofeedback wirelessly using headset and smart device as well as 
collect information from the scalp without the use of gel to connect electrodes.
Being able to do this on a regular basis would also increase the efficacy of the 
therapy and patients might be able to use neurofeedback in addition to or instead 
of commonly used pharmacological agents which are associated with significant 
adverse effect profiles. Therefore, home-based neurofeedback can act as a novel 
treatment option to provide pain relief to patients with much fewer side effects than 
current pharmacological agents [68].
8. Conclusions
Neurofeedback is a newly emerging technique which can be used to achieve brain 
states associated with increased resilience to pain. The results so far have been very 
promising not only in terms of improvement in chronic pain, where as many as half of 
the studies in the field have shown clinically significant reduction in clinical pain fol-
lowing neurofeedback, but also in terms of improvement in pain associated symptoms 
such as fatigue, depression, anxiety and sleep which have also been reported to improve 
with neurofeedback. Being able to target all of these co-morbidities holistically using 
neurofeedback is key for the overall improvement in the well-being of chronic pain 
patients because these factors are often interlinked and aggravate each other.
There is still a lot of work that needs to be done. Different aspects of training 
protocols, such as target signal, number of sessions, length of sessions and scalp 
region of interest, need to be optimized in order to identify parameters which lead 
not only to successful modulation of the brain activity but also a corresponding 
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the brain oscillations, as opposed to passive reception of stimulation [5]. We do 
not know which of these is a more efficient technique to alter brain oscillations yet. 
Furthermore, it is also unknown what mental strategies in particular are associated 
with changes in brain oscillations seen in the studies so far. Some of the common 
instructions given to patients undergoing training involve asking them to stay 
relaxed, imagining happy moments, revisiting happy memories and thinking about 
favorite family member or friends. However, none of the studies so far document 
which of these strategies actual work for the patients. Therefore, further qualitative 
studies are required to see what patients have been using to actively change their 
brain oscillations during neurofeedback in order to provide more focused instruc-
tions to patients undergoing training. Furthermore, studies should aim to analyze the 
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relation between behavioral change and changes in neurophysiological signal is key to 
understanding whether the pain relief is truly due to neurofeedback.
In addition to this, there is also a possibility that once the patients have been able 
to identify the mental strategy which allows them to achieve the desired brain state 
and practice in the neurofeedback setting for a number a sessions, they might be 
able to implement such mental strategies without the ongoing EEG signal feedback. 
It is not clear if this possible or how long it might take for an individual to become 
independent of the EEG feedback and still receive pain relief.
The current neurofeedback studies are highly heterogenous. It is unclear which 
brain regions, oscillations, feedback form or training length is required to optimize 
the improvement in pain. More studies are required comparing one aspect of the 
neurofeedback training program at once in order to determine which of these 
parameters provide the most therapeutic benefit.
Another area of uncertainty is the efficacy of neurofeedback in different pain 
conditions. Studies so far have shown that all chronic pain condition report pain 
reduction to some degree following neurofeedback. However, it is not known 
whether neurofeedback is better for some chronic pain conditions than others. It 
might be the case that neuronal changes seen following neurofeedback is linked to 
central sensitization only, in which case several chronic pain conditions may benefit 
from it equally as many pain conditions have this as the underlying pathology. 
However, we do not know whether it is equally as good at treating nociceptive pain 
as seen in conditions such as arthritis.
Furthermore, the role that neurofeedback will play in pain management in the 
future is not clear [16]. It is not clear whether it has the true potential to substitute 
pharmacological agents completely. It might be the case that it might reduce the 
escalation of opioid usage in this patient cohort. Hence further studies are needed 
to determine the maximum potential of this form of therapy.
6. Adverse effects associated with Neurofeedback
In general, neurofeedback is well tolerated with a minority of patients experienc-
ing mild adverse events. These adverse events are often self-limiting and tend to be 
controlled by decreasing the frequency of training [43, 48]. Adverse events seen 
in neurofeedback studies seem to be more common in certain patient groups than 
others. For instance, some individuals with spinal cord injury and central neuropathic 
pain have reported some hypersensitivity of soles of the feet due to recovery of pro-
prioception or spasms of the lower limb, [28, 48]. Patients with traumatic brain injury 
have reported an increase in nausea and the intensity of their headaches [39, 67]. It is 
difficult to confirm that these side-effects are due to NFB as these reported symptoms 
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are often seen in these conditions irrespective of provision of neurofeedback therapy. 
Overall, NFB is safe and well-tolerated in majority of patients in most clinical studies.
7. Delivery of home-based neurofeedback therapy
Neurofeedback has also been delivered in the home setting by a few recent 
studies [43, 48]. This can be achieved through the use of a headset which records 
activity from one single electrode, such as C4 [43, 48] or FP1 [39] and makes use of 
an app on tablets to analyze and showcase feedback to the individual [28, 48]. Such 
systems have been implemented in patients with central neuropathic pain [43, 48] 
as well as traumatic brain injury [39]. Patients could practice neurofeedback for 
5- or 10-minutes sessions as and when they wanted.
These studies have shown some promising results. With further expansion of this 
technology, it might be possible for individuals to benefit from neurofeedback at their 
home as and when required as patients have on average used neurofeedback 3–40 
times over the course of 2–3 months in these studies [43, 48]. Two of these studies have 
reported around 33% reduction in pain [43, 48] whereas one of them reported 16% 
reduction in pain [39] on average in participants who tried these home-based systems.
One of these studies also performed qualitative research on user experience 
following such home-based systems [43]. Overall, it was reported that the patient 
satisfaction score was high when measured using QUESB (Quebec User Evaluation of 
Satisfaction Questionnaire). According to the patients, the key factors which affected 
the frequency of their use of the home-based device were their health state, availability 
of free time and their intensity of pain. Patients also put effectiveness, ease of use and 
comfort as their main priority when using any such home-based device. Hence whilst 
the current home-based technology used in this study showed that it could record the 
data with decent quality, it also highlighted that patients wanted technology which 
was able to provide neurofeedback wirelessly using headset and smart device as well as 
collect information from the scalp without the use of gel to connect electrodes.
Being able to do this on a regular basis would also increase the efficacy of the 
therapy and patients might be able to use neurofeedback in addition to or instead 
of commonly used pharmacological agents which are associated with significant 
adverse effect profiles. Therefore, home-based neurofeedback can act as a novel 
treatment option to provide pain relief to patients with much fewer side effects than 
current pharmacological agents [68].
8. Conclusions
Neurofeedback is a newly emerging technique which can be used to achieve brain 
states associated with increased resilience to pain. The results so far have been very 
promising not only in terms of improvement in chronic pain, where as many as half of 
the studies in the field have shown clinically significant reduction in clinical pain fol-
lowing neurofeedback, but also in terms of improvement in pain associated symptoms 
such as fatigue, depression, anxiety and sleep which have also been reported to improve 
with neurofeedback. Being able to target all of these co-morbidities holistically using 
neurofeedback is key for the overall improvement in the well-being of chronic pain 
patients because these factors are often interlinked and aggravate each other.
There is still a lot of work that needs to be done. Different aspects of training 
protocols, such as target signal, number of sessions, length of sessions and scalp 
region of interest, need to be optimized in order to identify parameters which lead 
not only to successful modulation of the brain activity but also a corresponding 
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change in pain signals. Currently, it is not clear what neurofeedback protocol brings 
about maximum pain relief for patients.
Furthermore, identification of mental strategies which enable individuals to 
reach therapeutic brain states is also required, with the aim being that eventually 
individuals will be able to practice these strategies independent of the feedback 
system after an initial course of training sessions. Whilst, there is a lot of work 
to do, the results so far have been promising, opening window of opportunity to 
manage a number of chronic pain conditions at low cost and without the side effects 
associated with the currently available pharmacological agents.
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change in pain signals. Currently, it is not clear what neurofeedback protocol brings 
about maximum pain relief for patients.
Furthermore, identification of mental strategies which enable individuals to 
reach therapeutic brain states is also required, with the aim being that eventually 
individuals will be able to practice these strategies independent of the feedback 
system after an initial course of training sessions. Whilst, there is a lot of work 
to do, the results so far have been promising, opening window of opportunity to 
manage a number of chronic pain conditions at low cost and without the side effects 
associated with the currently available pharmacological agents.
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Abstract
Blockchain is a new emerging technology of distributed databases, which 
guarantees the integrity, security and incorruptibility of data by means of the 
cryptography. Such features are suitable for secure and reliable data storage. This 
chapter investigates the blockchain-based architecture with applications to medical 
health record or biofeedback information management. This framework employs 
the smart contract to establish a medical record management system to ensure the 
privacy of patients. Moreover, the blockchain technique accelerates the medical 
record or information exchange such that the cost of human resource is significant 
reduced. All patients can manage their individual medical records and information 
easily in the different hospitals and clinics. They also have the privilege to deal with 
and authorize personal medical records in the proposed management framework.
Keywords: blockchain, medical record, security, privacy
1. Introduction
The conventional medical record systems face the complicated administration 
procedure for data processing to ensure patients’ privacy, leading to the enormous 
waste of human resources. Such an architecture is obviously inefficient for the 
medical record exchange. Blockchain technique [1] has recently been adopted to 
secure medical data sharing and management. The cryptographic property in the 
blockchain networks guarantees the patients’ privacy. Data integrity and incorrupt-
ibility protect medical data from being tampered. The blockchain can be viewed 
as a distributed database, which stores data in each network nodes to avoid the 
halting problem. It thus provides higher stability, consistency and attack-resistance. 
The problem of distributed denial-of-service attacks (DDOS) in the conventional 
centralized framework can be solved by the blockchain technique. Deployment of 
blockchain in the medical record system not only provides the reliable service but 
also speeds up the medical record exchange. Owing to decentralization, the owner-
ship of the medical record is returned to the patients, allowing them to manage the 
medical record directly and take care of their own health.
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Biofeedback is a technique that uses electrical sensors to measure human body 
functions such as blood pressure and heart rate. Biofeedback aims to help learn your 
body condition and how it works. You may have biofeedback training in clinics, 
medical centers and hospitals. These measurements or data about biofeedback are 
thus important for the future therapy. Such data storage or management is therefore 
required and may be integrated with the medical record system.
In this chapter, we investigate the blockchain-based medical record manage-
ment systems in the literatures. The new medical record framework is thus 
proposed and implemented on an open-source platform, Ethereum. Note that 
Ethereum platform allows anyone to develop applications in blockchain networks. 
The Ethereum virtual machine (EVM) executes the smart contract on the virtual 
machine. With the aid of the smart contract, developers are able to put these codes 
on the blockchain. The codes will be automatically executed after the blockchain 
establishment. The medical record management system is developed by exploit-
ing the smart contract. The aim of the level of health care will be achieved in the 
proposed architecture via the smart contracts.
2. Literatures surveys
Authors in [2] presented the MedRec system, a decentralized medical record 
management system based on blockchain technology. There are three types of 
Ethereum smart contracts to associate patients’ medical data to allow third-party 
users to access the data. Yang et al. [3] further presented an attribute-based 
authentication mechanism on the MedRec system to enable the secure sharing 
of medical data. A high-level blockchain-based framework was designed in [4], 
where an identity-based authentication and key agreement protocol is applied 
to achieve user membership authentication. They also developed the MedShare 
[5] system to provide data provenance and control in cloud repositories among 
hospitals. Liang et al. [6] used the hyperledger fabric membership service and 
channel formation scheme to guarantee data privacy in a blockchain network for 
medical data sharing. The mobile application was also implemented to collect 
data from wearable devices for storage and sharing with healthcare providers. 
Patientory [7] is a peer-to-peer medical record data storage network. The soft-
ware framework in [7] was presented to address the authentication, authoriza-
tion, access control, data encryption interoperability enhancement and token 
management.
Authors in [8] proposed the MedChain system, where the timed-based smart 
contracts can interact with the various demands of health providers, patients and 
third parties. An incentive mechanism in [8] was also presented to leverage the 
degree of health providers about their efforts on maintaining medical records. In 
[9], an attribute-based signature scheme with multiple authorities was designed. 
There are multiple authorities without a centralized one to generate and deliver 
public/private keys of the patient, avoiding the escrow problem. Liu et al. [10] 
presented a healthcare insurance anti-fraud system based on blockchain. A hybrid 
architecture to facilitate access control of medical data was developed in [11]. A 
blockchain is used to manage identity and access control and acts as a tamper-proof 
log of access events. Hasavari et al. [12] introduced a combination of secure file 
transfer methods and blockchain techniques as a solution to record patient’s emer-
gency medical data such that ambulance crews can access and use it to provide high 
quality pre-hospital care.
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3.  Proposed Ethereum-based framework for medical record 
management
Instead of using the traditional centralized databases, the Ethereum-based block-
chain is applied to our designed system framework of medical record management to 
ensure the security of data. The medical records are stored within individual nodes 
in the blockchain networks by utilizing the smart contracts. The automatic smart 
contracts for the administration procedure are also designed with an aim to reducing 
the waste of human resource and speeding up the medical process.
The presented medical record management system is essentially rooted in the 
Ethereum-based blockchain architecture. The management framework is developed 
and established based on the relationship among the smart contracts. The proposed 
architecture is modified from the framework in [2]. The whole system is viewed 
as a private blockchain network, where all medical records are stored to guarantee 
data security, privacy and integrity. Innovatively combined with the data exchange 
mechanism in [13], the user identity is directly recognized by the system and the 
corresponding privilege is authorized to ensure data integrity in the blockchain 
networks.
3.1 Blockchain-based medical record management system
Figure 1 illustrates the proposed medical record management system with smart 
contracts. There are three types of smart contracts, including registrar contract, 
patient-provider relationship contract and summary contract.
3.1.1 Registrar contract (RC)
Similar to [2], this contract maps member identification strings to the Ethereum 
address identity. All the registered members are divided into two groups, patients 
and medical personnel. Each identity has different access rights for the proposed 
system.
Authorized privilege of patients:
a) Review their own medical records. b) Authorize their own medical records.
Authorized privilege of the medical personnel:
a) Create/modify the authorized medical records. b) Review the authorized 
medical records. Notice that different kinds of the medical personnel has  
different authorized or restricted rights.
3.1.2 Patient-provider relationship contract (PPR)
Each PPR smart contract is a medical certificate. The PPR smart contract is uti-
lized to record the current situation of medical records, details of diagnosis and the 
access permission of different summary contracts. Sometimes other relevant PPR 
diagnostic address information will also be included. All summary smart contracts 
must be licensed by the owner of the PPR contract to access the PPR smart contract.
As shown in Figure 2, the medical personnel will be allowed to modify or read 
only based on the access right in the summary contracts after getting the permits. 
Moreover, the administration system can track the current diagnosis by the assis-
tance of the PPR contract.
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3.1.3 Summary contract (SC)
This contract holds a list of references to PPRs, locating patients’ medical record 
history. The patient-oriented medical record classification structure in the proposed 
system is designed. Each record is viewed as an PPR smart contract. The proposed 
medical record structure is shown in Figure 3.
3.2 Private blockchain network
The deployment of the private blockchain network is illustrated in Figure 4, 
which is applied for the level of care. The main private blockchain network is plotted 
Figure 2. 
Authorization procedure of getting medical record permission.
Figure 1. 
Proposed smart contract-based medical management system.
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by the solid lines. The critical network devices are maintained by the medical centers 
or hospitals, and the distributed databases among them must be synchronized. 
The clinics only need to synchronize with the nearby blockchain network nodes to 
ensure their database stay latest and correct.
Dotted lines stand for the data requests to the blockchain network from patients 
whom made inquiry for medical record. In this case, the main blockchain network 
nodes (e.g. the medical center or hospital) are responsible to deal with the requests 
since their network equipments are capable of handling the heavy network traffic 
due to plenty of requests. As a primary node in blockchain network, the synchroni-
zation speed and correctness should be guaranteed.
Figure 3. 
Proposed personal medical record.
Figure 4. 
Deployment of private blockchain.
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3.1.3 Summary contract (SC)
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3.3 System workflow
How the proposed management system works is presented in Figure 5.
3.3.1 New entry
The medical personnel uploads the diagnosis to provider B Node.
3.3.2 External process and outside process
The external management system detects the updates from the blockchain 
databases, automatically validates the latest data and notifies the patients of the new 
updates.
3.3.3 Update nodes
The blockchain network automatically synchronizes all nodes and offers the 
latest information to the patient node.
3.3.4 Notification from provider B
The patient will be notified by the information about who updated the medical 
record and then checks these updates.
3.4 Limitations
With the blockchain-based technique for distributed databases, the additional 
network facilities and storage devices for network nodes are required to stabilize 
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3.5 Comparison with other frameworks
Table 1 compares the proposed medical record management framework with 
the existing architectures based on blockchain techniques. Security metrics (iden-
tification, data authenticity, data encryption), architecture metrics (blockchain 
type, data storage) and functionality metrics (smart contract) are all taken into 
consideration.
Table 2 also surveys the existing systems. The proposed framework verifies 
legitimate users before performing the registration process, check the identity to 
ensure that personal information is only given to authorized users.
4. Conclusions
This chapter investigated the blockchain-based and patient-oriented medical 
record system with the smart contract on EVM. In the future, the drug pedigree 
may be included into the blockchain. The drug traceability is thus carried out for 
efficient management and control.
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